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Abstract 
 
The following research project was conducted in order to evaluate the antimicrobial efficacy 
of an alcohol-free skin concentrate formula intended for use on hands. Substitute compounds 
for alcohol in antimicrobial formulae is receiving much interest due to the tendency of alcohol 
to dry and irritate the skin after repeated use. As well as assessing the formula’s efficacy, the 
individual components were assessed using a series of certified antimicrobial assays. Chief 
among the components of the skin concentrate formula was chlorhexidine digluconate, a 
prominent potent antimicrobial compound. The bacterial strains selected for exposure to 
antimicrobial susceptibility assays were Escherichia coli, Staphylococcus aureus, and 
Pseudomonas aeruginosa. Furthermore, in addition to assessing antimicrobial potency, parallel 
cytotoxicity studies were performed on a mammalian cell line, to determine the extent of 
potential toxic behaviour demonstrated by the skin concentrate and its constituents. The chosen 
mammalian cell viability assay was the MTT (3-4(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide tetrazolium) reduction assay. The selected mammalian cell line 
for cytotoxicity studies was A549, which is a lung-derived carcinoma cell line. Topical 
antibacterial compounds are commonplace in the healthcare, domestic and industrial 
environments; hence the importance of assessing their cytotoxicity cannot be undervalued. 
 
Silver is recognised as an effective antimicrobial, especially in the healthcare setting where it 
is incorporated into wound dressings to combat external infections. Silver sulfadiazine and 
silver nitrate represent two of the most common silver-containing antimicrobial compounds. 
For comparison against silver containing compounds, silver ions were generated in solution 
using a Dowex cation exchange resin for subsequent antimicrobial susceptibility and 
cytotoxicity testing. 
 
The potent antimicrobial efficacy of chlorhexidine digluconate, alone and in combination with 
other excipients, was observed. All three strains proved to be susceptible. Furthermore, silver 
displayed similar potent antimicrobial activity against all three strains. However, cytotoxic 
properties were observed for chlorhexidine digluconate and silver. Therefore, while 
chlorhexidine diguconate is a distinguished antimicrobial compound, the cytotoxic properties 
associated with it suggest a replacement compound with reduced cytotoxic properties may be 
required for incorporation into the formula. 
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Introduction 
 
Bacteria represent the most abundant organisms on the planet and their biomass by far 
outweighs that of any other organism. Understandably, one would perceive humans as the 
dominant species on the planet and consider the current era as a principally mammalian one. 
However, bacteria have been the most dominant organisms for most of the time life has 
occupied the planet. Remarkably, there are more bacterial cells within the human body than 
there are human eukaryotic cells. In addition, bacteria have the ability to endure a wide variety 
of environments, from the coldest to the hottest locations on earth. As a consequence, bacteria 
are more adaptable than any other organism. 
 
On a daily basis, the majority of microorganisms encountered by humans are innocuous, 
thereby allowing peaceful coexistence (Stephens & Murray, 2001). According to 16S 
ribosomal RNA gene sequencing, the majority of bacterial inhabitants associated with 
conventional skin flora belong to four phyla: Actinobacteria, Bacteroidetes, Firmicutes, and 
Proteobacteria. In addition, the aforementioned phyla constitute the majority of bacteria 
inhabiting the gastrointestinal tract and oral cavity. Furthermore, microbes inhabiting the skin 
can indirectly assist host immunity by competing for nutrients and space, thereby inhibiting the 
growth of pathogenic bacteria (Sandford & Gallo, 2013). 
 
The distribution of transient bacteria by hands plays a considerable role in the direct and 
indirect transmission of disease. Furthermore, a single source of infection has the capacity to 
spread to other people, either by direct means or indirect means. For example, a study analysing 
the transmission of Salmonella from one sick family member to others established that the 
chance of another family member acquiring the infection was as high as 60 %. Therefore, it is 
necessary to decrease the number of bacteria that can be transferred to shared inanimate objects, 
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food, or other people. Moreover, proactive risk management steps are essential to assist in 
disrupting the transmission of potentially pathogenic microorganisms to oneself, to others, and 
to inanimate objects (Fischler et al., 2007). 
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Crystal Clear 
 
The following MSc (By Research) project was conducted with financial support from Crystal 
Clear International Limited. Crystal Clear International Limited is committed to enhancing 
treatments in the sphere of skincare. From progressive beauty technology to acclaimed skincare 
products, Crystal Clear covers an extensive range of requirements. Furthermore, the aim of the 
project was to evaluate the antimicrobial activity of a current disinfectant hand rub formula, 
under the ownership of Crystal Clear International Limited, against different test organisms. In 
addition, antimicrobial ability was evaluated using internationally recognised assays for the 
assessment of novel antimicrobial compounds. As well as assessing the antimicrobial activity 
of a hand rub formula, the constituents of the formula were separately assayed in order to 
compare their individual antimicrobial capabilities. Moreover, alternative formula constituents 
were assayed in order to identify possible replacements. In addition to examining the 
antimicrobial activity of the hand rub formula and its individual components, potential 
cytotoxicity towards mammalian cells was assessed. Furthermore, antimicrobial assays 
combined with cytotoxicity investigations provided a comprehensive understanding of the 
overall efficiency of the hand rub formula and its individual constituents. 
 
The hand rub solution consisted of five principal components with varying functions within 
the formula. The five principal components are water, tetrasodium ethylenediamine tetraacetate 
(EDTA), didecyldimethylammonium chloride (DDAC), a mixture of benzyl-C12-14-
alkyldimethylammonium chlorides collectively referred to as benzalkonium chloride (BAC), 
and chlorhexidine digluconate. EDTA is included in many cosmetic formulations as a chelating 
agent and its function is to combine with polyvalent metal ions in solution to generate soluble 
ring structures. Furthermore, EDTA is utilised in foods, drugs, and cosmetics to neutralise the 
adverse effects of metal ions on the stability of cosmetic products (Lanigan & Yamarik, 2002). 
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DDAC and BAC belong to a group of compounds called quaternary ammonium compounds 
(QACs). The general structure of QACs includes a positively charged nitrogen atom displaying 
four bonds. In the case of fully substituted QACs, the nitrogen atom can attach to four nonpolar 
alkyl or aryl chains. In addition, the counter-ion is perceived as less fundamental in many of 
the applications of QACs, however it can have an impact on solubility. Moreover, the 
amphiphilic characteristics of QACs contributes to their diverse applications, such as 
surfactants, dyes, neuromuscular blocking agents, and disinfectants. Furthermore, BAC and 
DDAC represent two of the most common commercial mono-cationic QACs in today’s market 
(Jennings, Minbiole & Wuest, 2015). Chlorhexidine digluconate represents the principal 
antimicrobial component in the formula; demonstrating activity against both Gram-positive 
and Gram-negative bacteria. In addition, chlorhexidine digluconate has been used extensively 
in surgical hand-wash formulations, as an antiseptic, in topical treatments for wound sepsis, as 
an anti-plaque agent, and within topical slow release vehicles for the treatment of periodontal 
disease (Gilbert & Moore, 2005). 
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Background Information on Bacteria 
 
 
Bacteria as Prokaryotes 
 
Bacteria are recognised as a biological domain of the living world; a domain is defined as the 
highest rank in the classification system of organisms. There are three cellular domains: 
Bacteria, Eukarya, and Archaea. The three domains of life arise from observations regarding 
differences in cellular structure and biochemical functioning. Furthermore, these distinctive 
traits include different deoxyribonucleic acid (DNA) replication apparatus for bacteria, unique 
ether-linked isoprenoid membrane phospholipids in archaea, and the existence of various 
complex organelles in eukaryotes (López-García & Moreira, 2015). 
 
Bacteria are categorised as prokaryotes; unicellular organisms which lack a membrane-encased 
nucleus and specialised membrane-bound organelles responsible for carrying out specific 
functions within a eukaryotic cell. For example, mitochondria generate the energy required to 
drive activities within animal cells from the degradation of food molecules. Surrounding the 
cellular contents is a plasma membrane that is composed of fatty acids; molecules that are 
characterised by having a hydrophilic region and a hydrophobic region. When a large amount 
of these molecules come into contact they spontaneously self-assemble into two distinct layers, 
with their hydrophobic regions assembling on the interior of the membrane and their 
hydrophilic regions assembling on the exterior. Cells are distinct entities and the presence of a 
boundary in the form of a plasma membrane further strengthens this observation. In addition 
to a membrane which regulates the passage of molecules across it with the aid of membrane-
associated proteins, virtually all bacteria possess a cell wall comprising of sugar moieties cross-
linked by polypeptides known as peptidoglycan. The main purpose of the cell wall is to protect 
the cell from mechanical injury and to prevent cell lysis due to osmotic pressure. Prokaryotic 
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cells differ greatly from eukaryotic cells with regards to the organisation of intracellular 
constituents; more specifically the DNA molecules within a typical eukaryotic cell are 
intricately assembled into multiple, linear chromosomes encased within a nuclear envelope and 
separate from the plethora of intracellular processes occurring within the cell. In contrast, the 
genetic material within a typical bacterial cell is assembled into a single, circular molecule 
which is not contained within a protective nucleus and is free-flowing within the cytoplasm. 
 
 
DNA Replication 
 
Faithful replication of genetic information, which is incorporated within the double helix of 
DNA, is crucial for the inheritance of traits that determine the phenotype of cells and the 
organism. The entire process of genome replication can be divided into a variety of sub-
processes; the core of DNA replication is the intracellular machinery that undergoes the process 
of copying DNA, including the proteins that initiate the entire process and the proteins that 
generate two copies of DNA from one copy. Furthermore, bacterial genomes are considerably 
smaller than eukaryotic genomes; a single molecule of DNA within a bacterium that resides in 
the gut flora of humans is approximately 5 million base pairs in length. In contrast, the single 
DNA molecule in the largest human chromosome is 245,203,898 base pairs in length, 
consequently the DNA replication process occurring within both cell types will exhibit 
different features (O’Donnell, Langston & Stillman, 2013). 
 
A single bacterium ordinarily contains one chromosome with a single location defined as the 
“origin”, where the process of replication begins. In bacteria, origins are well-defined 
sequences which are the target for replication initiator proteins to bind to and instigate the 
process of replication (O’Donnell et al., 2013). Bacterial, archaeal, and eukaryotic cells all 
utilise origin-binding proteins derived from the AAA+ superfamily; a collection of functionally 
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diverse NTPases which obtain energy from ATP hydrolysis in order to engage in molecular 
remodelling events (Snider, Thibault & Houry, 2008). In bacteria, multiple copies of DnaA, an 
origin-binding protein, assemble together to produce a helical filament which unwinds a dense 
A/T base-pair region in the origin sequence, thus generating a single–stranded DNA “bubble”. 
The primary objective of origin-binding proteins is to facilitate the loading of helicase proteins, 
known as DnaB, onto the single strand of DNA. DnaB comprises of six subunits; a feature 
shared by all three domains of life and migrates along the single strand of DNA representing a 
wedge to prise the parental duplex apart. DNA polymerase is restricted to being solely capable 
of covalently linking nucleotides to an existing single strand of DNA, thus the synthesis of a 
primer is required to initiate cellular DNA replication. In Escherichia coli, the single-subunit 
enzyme, DnaG, catalyses the synthesis of the primer by temporarily binding to the helicase; 
the newly synthesised primer is approximately 12 nucleotides in length. The replication 
apparatus responsible for simultaneously generating two daughter duplexes is commonly 
referred to as a replisome; a multiprotein complex. The bacterial replisome is coordinated by 
the clamp loader which attaches to three molecules of DNA polymerase . Furthermore, the 
clamp loader also binds to the helicase and continually compiles -clamps onto primed 
locations as they are generated by primase for DNA polymerase  to interact with in order to 
elongate a new single strand of DNA. The presence of a sliding clamp in the replisome is to 
allow DNA polymerase  to catalyse the formation of many covalent links between 
nucleotides each time it is bound to a DNA molecule; this is made possible by strengthening 
the association between the enzyme and the DNA molecule (O’Donnell et al., 2013). 
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Gram-negative & Gram-positive Bacteria 
 
Most types of bacteria can be differentiated into two distinct groups based on the chemical 
components of their cell walls; a feature shared by plant eukaryotic cells. Furthermore, the 
Gram stain is a technique which classifies bacteria as either Gram-positive or Gram-negative. 
Gram-negative cell walls, such as those found in E. coli, usually consist of a thin peptidoglycan 
layer with an outer membrane enclosing it; the outer membrane exhibits a chemically distinct 
composition from the inner plasma membrane. In contrast, Gram-positive cell walls, such as 
those found in Staphylococcus aureus, are much thicker and Gram-positive bacteria lack an 
outer membrane. 
 
Both membranes present in Gram-negative bacteria contain proteins that aid in the migration 
of matter and information. However, both membranes exhibit distinctive structural and 
functional differences. The lipid content of the inner cytoplasmic membrane is entirely 
composed of phospholipids, which are uniformly distributed among the inner and outer leaflet. 
In contrast, the outer membrane of Gram-negative bacteria is highly asymmetric; the inner 
leaflet exhibits identical lipid composition to the cytoplasmic membrane and the outer leaflet 
contains lipopolysaccharides. With regards to the functional differences, the outer membrane 
is significantly leakier than the cytoplasmic membrane due to the pore-forming proteins 
situated in the outer membrane (Koebnik, Locher & Van Gelder, 2000). Outer membrane 
proteins (OMPs) are integral membrane proteins which display a -barrel structure in the 
membrane, with short loops between strands on the periplasmic side and large protracted loops 
on the extracellular side. As they are protruding into the outside of the bacterial cell, OMPs 
have a variety of roles, such as serving as adhesion factors in virulence and acting as channels 
for the uptake of nutrients (Rollauer, Sooreshjani, Noinaj & Buchanan, 2015). 
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Figure 1. A Gram stain image of a culture of Gram-positive Staphylococcus aureus. The cells 
appear purple after staining due to the retention of crystal violet dye. 
 
 
Figure 2. A Gram stain image of a culture of Gram-negative Escherichia coli. The cells do not 
retain the purple colour characteristic of crystal violet following the application of alcohol. 
Furthermore, the cells appear red due to the retention of the counter dye safranin. 
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Metabolic Pathways 
 
Despite the more complex structural nature of typical eukaryotes, both cell types share many 
common attributes, such as possessing a plasma membrane and having a common set of 
metabolic pathways. Essentially, a metabolic pathway encompasses a sequence of separate 
reactions, each governed by a specific enzyme, which facilitate a complex chemical 
transformation. In cells, particular molecules serve as fuel and release chemical energy that is 
exploited to generate adenosine triphosphate (ATP). In essence, ATP comprises of an 
adenosine molecule bonded to three phosphate groups and is considered to be a high-energy 
molecule due to the presence of energy-rich phosphate bonds. Furthermore, ATP is central to 
the energy transformations of all living organisms and can be hydrolysed in various locations 
within a cell to liberate free energy to drive endergonic reactions. In non-photosynthetic cells, 
sugar glucose represents the most common chemical fuel and glucose catabolism involves 
liberating the energy stored within the covalent bonds. 
 
Glycolysis is an example of a metabolic pathway which occurs in the cytoplasm of both 
eukaryotes and prokaryotes, with the former transporting the end product of glycolysis to the 
mitochondrial matrix. Glycolysis is the first step in glucose catabolism which encompasses ten 
enzyme-catalysed reactions to generate pyruvate; a three-carbon molecule from glucose. 
Glycolysis liberates relatively little of the energy that is contained within a glucose molecule; 
following glycolysis is the citric acid cycle and oxidative phosphorylation which both release 
much more usable energy. Specifically, glycolysis generates four ATP molecules from one 
molecule of glucose, yet the initial steps of glycolysis consume two molecules of ATP, thereby 
establishing a net production of two ATP molecules. 
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Pyruvate oxidation represents the next step in the aerobic catabolism of glucose, which occurs 
in the plasma membrane of prokaryotes and the mitochondrial matrix of eukaryotes. Pyruvate 
oxidation links the process of glycolysis and subsequent oxidative reactions to liberate energy 
from the catabolism of glucose. In general, pyruvate oxidation involves the generation of a 
two-carbon acetate molecule and carbon dioxide from the oxidation of pyruvate. Following the 
generation of acetate, coenzyme A is bound to the newly formed acetate to produce acetyl 
coenzyme A (acetyl CoA). Furthermore, the principal role of acetyl CoA is to donate the acetyl 
group to oxaloacetate, which initiates the citric acid cycle. Additionally, pyruvate oxidation, 
the citric acid cycle, and oxidative phosphorylation are collectively referred to as cellular 
respiration. However, in the absence of oxygen, glycolysis is followed by fermentation which 
involves the conversion of pyruvate into lactic acid or ethanol, and is associated with the 
incomplete oxidation of glucose. 
 
The citric acid cycle represents one of life’s most significant energy-reaping pathways and 
completes the oxidation of glucose to carbon dioxide. The citric acid cycle occurs within the 
cytoplasm of prokaryotes and within the mitochondrial matrix of eukaryotes. The citric acid 
cycle comprises of eight reactions and concludes with the regeneration of the starting material; 
oxaloacetate. As well as carbon dioxide, the citric acid cycle generates reduced electron carriers 
in the form of nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide 
(FADH2). 
 
The process of ATP synthesis is referred to as oxidative phosphorylation and involves the re-
oxidation of electron carriers. Oxidative phosphorylation occurs in the mitochondria of 
eukaryotes and the plasma membrane of prokaryotes. Furthermore, the process of oxidative 
phosphorylation is divided into two components; electron transport and chemiosmosis. 
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Electron transport involves the migration of electrons down a wire of protein complexes 
embedded in the inner mitochondrial membrane called a respiratory chain; stimulating the 
movement of protons out of the mitochondrial matrix and across the inner mitochondrial 
membrane by means of active transport, thus establishing a proton concentration gradient. In 
addition, the imbalance of protons establishes a charge difference between the intermembrane 
space and the matrix, since protons bear a positive charge. The resulting electric field across 
the membrane can be likened to a charged-up battery. Furthermore, the proton concentration 
gradient and the electric charge difference combine to establish a source of potential energy 
called the proton-motive force. This force drives protons back across the membrane into the 
mitochondrial matrix through a specific proton channel called ATP synthase. The proton-
motive force and ATP synthase couple together in a process known as chemiosmosis. ATP 
synthase links the movement of protons back across the membrane with the synthesis of ATP. 
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Pathogenesis  
 
 
Bacteria as Pathogens 
 
The majority of microorganisms that humans encounter on a daily basis are innocuous; 
allowing these microorganisms to coexist peacefully with humans. However, some of these 
microorganisms have siblings that are capable of triggering disease. E. coli represents a classic 
example of a species of bacteria that can give rise to commensal strains and pathogenic strains. 
E. coli is found in the intestines as commensal bacteria; the colonisation of the gastrointestinal 
tract by large numbers of commensal bacteria protect humans from foodborne bacteria by 
presenting these pathogenic bacteria with a competitive disadvantage. On the other hand, 
pathogenic E. coli strains are capable of causing a broad range of human diseases, such as 
watery diarrhoea and haemolytic-uremic syndrome; the latter being associated with the 
serotype E. coli O157:H7 (Stephens & Murray, 2001). Pathogenic bacteria exploit an array of 
mechanisms to trigger disease in human hosts. In addition, bacterial pathogens express an 
extensive range of molecules that bind to host cell targets in order to elicit a variety of different 
host responses. Furthermore, an approach to combating bacterial disease is the identification 
and characterisation of the diverse molecular strategies utilised by pathogenic bacteria to 
trigger disease (Wilson et al., 2002). 
 
Substantial influx in data regarding DNA sequences, clever utilisation of polymerase chain 
reaction (PCR) techniques, and the impact of crystallographic methods indicate that there are 
common strategies utilised by a bacterium in order to become a pathogen. Microbial proteins, 
usually in the form of enzymes, which are secreted from pathogenic bacteria and are able to 
kill host cells at low concentrations are called exotoxins. Exotoxins alone have the capacity to 
inflict most of the clinical features associated with cholera and tetanus, thereby often 
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representing a central role in the pathogenesis of microbial disease (Finlay & Falkow, 1997). 
Proteinaceous toxins can be transported to eukaryotic cells by two different methods: 
distribution into the surrounding extracellular environment or direct insertion into the 
cytoplasm of the host cell (Wilson et al., 2002). Toxins are differentiated into groups based on 
their structural homology and biochemical activity. Moreover, A-B toxins represent a very 
common type of endotoxin which include two subunits; the B subunit and the A subunit. The 
B subunit facilitates the attachment of the toxin to the host cell receptor and the subsequent 
insertion of the toxin into the host cell. The A subunit bears the enzymatic activity which acts 
on the host cell. The enzymatic activity demonstrated by the A-subunit varies among toxins; 
ADP-ribosylating activity and proteolytic activity are examples of the activity that can be 
demonstrated by the A-subunit. The B domain is subject to much variation, presumably to 
accommodate for attachment specificities associated with different hosts and tissues. Examples 
of A-B toxins include the pertussis toxin, produced by Bordetella pertussis, and the cholera 
toxin, produced by Vibrio cholerae. In addition, proteolytic toxins represent another category 
of exotoxin and their mode of action includes the degradation of specific host proteins which 
gives rise to some of the distinctive clinical symptoms of the disease. Furthermore, both 
Clostridium tetani and Clostridium botulinum release toxins that target synaptobrevins which 
in turn inhibits the release of neurotransmitters, thereby leading to different types of paralysis 
(Finlay & Falkow, 1997). 
 
Microbial pathogens require the means to adhere to host surfaces for successful colonisation 
and the subsequent production of disease. In addition, identifying the specific role of a 
particular adhesin molecule is difficult since an individual pathogen can express numerous 
adherence factors (Finlay & Falkow, 1997). Host surfaces include skin, mucous membranes, 
and deeper tissues. Furthermore, hosts can deploy numerous mechanical forces to detach 
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microbes from these surfaces, such as saliva secretion, coughing, sneezing, mucous flow, 
peristalsis, and blood flow (Wilson et al., 2002). Bacterial adhesins are elements on the cell 
surface which facilitate the adherence of bacteria to host surfaces. Additionally, they can be 
divided into two major categories; pili and non-pilus adhesins. The conservation of the 
molecular machinery associated with the biogenesis and subsequent assembly of pili onto 
bacterial surfaces constitutes one of the major features among diverse pili. The family of P pili 
represent one of the best-studied examples of the processes involved in pilus assembly. P pili 
that are expressed on the surfaces of some E. coli strains are thought to be crucial in the 
pathogenesis of pyelonephritis; a disease characterised by urinary tract colonisation followed 
by infection of the kidney. The specificity for a certain tissue is possibly dictated by the 
presence of a host receptor which is recognised by a particular adhesin. Furthermore, 
interaction with the host receptor is ensured by the position of the adhesin at the distal tip of 
the pilus. PapG is an adhesin molecule belonging to the P pili family and is located at the distal 
end of the pilus rod. PapG binds to the -D-galactopyranosyl-(1-4)--D-galactopyranoside 
(galabiose) receptor; a member of a globoseries of glycolipids which are located on the host 
cells lining the upper urinary tract (Finlay & Falkow, 1997). 
 
Afimbrial adhesins are protein adherence factors, although they do not assemble into long, 
polymeric fimbrial structures. In addition, afimbrial adhesins commonly interact more 
intimately with the host cell (Wilson et al., 2002). B. pertussis is a respiratory mucosal pathogen 
that causes pertussis; a disease characterised by symptoms similar to those produced by the 
common cold which are followed by extended periods of damaging coughing fits. B. pertussis 
secretes an afimbrial adhesin known as filamentous haemagglutinin (FHA); a 220 kilodalton 
(kDa) polypeptide which facilitates the attachment of bacteria to ciliated respiratory cells and 
alveolar macrophages (Sandros & Tuomanen, 1993). FHA contains the arginylglycylaspartic 
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acid (RGD) sequence; a eukaryotic recognition motif which enables FHA to bind to the cell-
surface integrin, CR3, on leukocytes. Subsequent bacterial uptake into macrophages does not 
initiate oxidative burst; promoting intracellular survival (Finlay & Falkow, 1997). 
Additionally, FHA contains a carbohydrate recognition domain which mediates the attachment 
of bacteria to ciliated cells. Furthermore, bacterial strains with in-frame deletions of nucleotide 
sequences that affect the amino acid sequences defining the carbohydrate recognition domain 
fail to attach to ciliated cells and macrophages (Sandros & Tuomanen, 1993). 
 
Pathogens can further infiltrate the host in order to continue the infection cycle. The pathogenic 
principle which is characterised by further permeation into a host cell is referred to as invasion. 
Invasion can be divided into two categories; extracellular and intracellular. Extracellular 
invasion arises when a microbe breaches the barriers of a tissue in order to spread within a host 
while residing outside of host cells. S. aureus represents one of the bacterial species which 
utilises the strategies associated with extracellular invasion. The features of extracellular 
invasion include the release of several enzymes that degrade host cell molecules, such as 
hyaluronidase and nuclease. Hyaluronidase cleaves proteoglycans in connective tissue and 
nuclease digests released DNA. Furthermore, extracellular invasion enables pathogenic 
bacteria to access niches in tissues from where they are capable of multiplying, progressing to 
other locations, producing toxins, and generating inflammatory responses. Intracellular 
invasion arises when a microbe infiltrates the cells of a host tissue and subsequently prospers 
within the intracellular environment. Some pathogens, such as many species belonging to the 
Rickettsia genus, rely on intracellular invasion of mammalian cells to sustain their own 
lifecycles. On the other hand, facultative intracellular pathogens utilise their ability to survive 
within host cells as a means of proliferation, or dissemination to other tissues. In addition, the 
genes that allow pathogens to invade non-phagocytic cells have been established to encode an 
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evolutionarily related type  protein secretion pathway. Furthermore, the type  protein 
secretion pathway inserts signalling proteins from the microbe into the host cell, which 
stimulate host cell signalling pathways to coordinate the uptake of the microbe (Wilson et al., 
2002). 
 
The invasion system found in Yersinia pseudotuberculosis and Yersinia enterocolitica 
represents a well-studied model of bacterial entry into epithelial cells. Both Y. 
pseudotuberculosis and Y. enterocolitica have a chromosomal gene that dictates the formation 
of invasin; an outer membrane protein which facilitates attachment and access into non-
phagocytic cells (Finlay & Falkow, 1997). Invasin coordinates the uptake of bacteria into 
mammalian cells by way of binding to 1 integrins; membrane  heterodimeric receptor 
proteins that facilitate adhesion between cells, the extracellular matrix, and pathogens. 
Additionally, 1 integrins display a much higher affinity for invasin than the more common 
extracellular matrix ligands, such as fibronectin, which contributes to the eventual uptake of 
the microorganism (Gillenius & Urban, 2015). For many intestinal microorganisms, the initial 
cell type that is encountered is the microfold cell (M cells) which can be found distributed 
within the epithelium or over lymphoid patches. Consequently, bacterial interaction with M 
cells instigates the binding of invasin to the 1 integrin followed by internalisation of the 
microbe (Isberg & Van Nhieu, 1994). 
 
 
Enteric Pathogenic E. coli serotype O157:H7 
 
The serotype E. coli O157:H7 represents a distinct antigenic-related variation within the 
species of E. coli. Essentially, serotyping identifies strains of bacteria based on their cell surface 
antigens. Furthermore, E. coli O157:H7 expresses on its cell surface the O157 antigen; the 
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outermost component of a liposaccharide molecule that protrudes from the outer membrane of 
the cell (Wolf, 1997). The repeating monomeric unit structure which constitutes the O-
polysaccharide exhibits vast diversity with regards to the type of carbohydrate monomer and 
the presence, or absence of non-carbohydrate substituents. In addition, the position and 
stereochemistry of the O-glycosidic linkages are subject to much variation. Furthermore, the 
structure of the O-polysaccharide within an organism determines its serological specificity 
(Whitfield & Raetz, 2002). Interestingly, Boyer, Sumner, Williams, Kniel & McKinney (2011) 
demonstrated that the absence of the O157 antigen reduced the cells ability to attach to the 
surface of lettuce. Moreover, the absence of the O157 antigen increased the hydrophobic 
characteristics of the cell, which indicates that the hydrophobic properties of a cell may 
influence the cells ability to attach to food surfaces. Additionally, the physiochemical 
properties of the cell were altered by the absence of the O157 antigen, yet only hydrophobicity 
influenced the cells ability to attach to the surface of lettuce. In contrast, the H7 antigen is 
proteinaceous and incorporated into the structural components of the flagellum; a rigid helical 
tail which is driven by a molecular motor at its base (Wolf, 1997). 
 
E. coli O157:H7 is a harmful foodborne pathogen that is capable of triggering severe diseases 
in humans worldwide; this serotype represents a significant public health concern in North 
America, Europe, and other areas of the world. E. coli O157:H7 is categorized as 
enterohemorrhagic; a subset of pathogenic E. coli that are capable of producing Shiga toxins 
(Stxs). Furthermore, Shiga toxins cause haemorrhagic colitis (HC) and haemolytic uremic 
syndrome (HUS). Pathogenic E. coli are divided into categories based on serogroups, 
pathogenicity mechanisms, clinical symptoms, or virulence factors. Enterohemorrhagic E. coli 
(EHEC) comprise of several pathogenic serotypes that are regularly linked with human 
diseases; E. coli O157:H7 represents the most frequently isolated serotype from ill persons in 
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the United States, Japan, and the United Kingdom. Despite the total number of case numbers 
associated with E. coli O157:H7 infections being lower than those of other enteric pathogens, 
such as Salmonella spp, the diseases produced by E. coli O157:H7 result in higher 
hospitalisation and fatality rates. Furthermore, cattle are a major reservoir of E. coli O157:H7, 
as the presence of this harmful serotype within cattle does not induce any of the symptoms 
associated with E. coli O157:H7 colonisation within humans (Youn Lim, Yoon & Hovde, 
2010). The foremost virulence properties associated with E. coli O157:H7 are adherence to 
mucosal cells and the production of Shiga-like toxins (Griffin & Tauxe, 1991). The 
colonisation of the intestinal mucosa by E. coli O157:H7 is characterised by the generation of 
the attaching and effacing (A/E) lesion. The A/E lesion is generated by effacement of the 
microvilli followed by bacterial adherence to the epithelial cell membrane (Youn Lim et al., 
2010). 
 
 
Shiga Toxin 
 
The Shiga toxin (Stx) is among one of the most potent bacterial toxins. Stx occurs in Shigella 
dysenteriae type 1 and some serotypes of E. coli; the Shiga toxin found in specific strains of E. 
coli is referred to as Stx1a in order to distinguish it from the toxin produced by Shigella 
dysenteria. In addition, some strains of E. coli produce a second, antigenically distinct toxin 
known as Stx2a. Interestingly, strains that produce Stx2a are more commonly linked with the 
life-threatening haemolytic uremic syndrome (HUS). Furthermore, Stx is composed of two 
major subunits; the A subunit and the B subunit. The A subunit consists of 293 amino acids 
and consists of an enzymatic region that facilitates the cytotoxicity of the toxin. The B subunit 
is composed of five structurally identical subunits which assemble to form a pentamer; the A 
subunit and the B subunit interact non-covalently (Melton-Celsa, 2014). The A subunit 
demonstrates RNA N-glycosidase activity against 28S rRNA; a component of the large subunit 
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that forms part of eukaryotic ribosomes, ultimately obstructing the process of protein synthesis 
and inducing cellular apoptosis. In addition, the B subunit targets globotriaosylceramide-3 
(Gb3); a glycolipid cellular receptor which is expressed on different cell types depending on 
the host (Nguyen & Sperandio, 2012). Once the Shiga toxin has been inserted into the gut 
lumen it targets the Gb3 receptor by means of translocation across the intestinal epithelium into 
the underlying tissues and bloodstream. Additionally, high concentrations of the Gb3 receptor 
are present in renal tubular cells and microvascular endothelial cells. The locations of the 
aforementioned types of cells are commonly found in the kidney, gut, and brain. Furthermore, 
the locations of these cells explain the clinical manifestations of HUS (Clements, Young & 
Constantinou, 2012). Furthermore, cattle lack expression of the Gb3 receptor on their vascular 
endothelium, thus allowing E. coli O157:H7 to thrive within cattle without presenting any of 
the adverse effects associated with the pathophysiology of the Shiga toxin (Nguyen & 
Sperandio, 2012). 
 
 
Attaching and Effacing Lesions 
 
The gastrointestinal epithelium represents a significant defence barrier against disease-causing 
microbes. However, enteric pathogens, such as E. coli O157:H7, have developed virulence 
traits that allow them to colonise and penetrate this barrier. Moreover, several important 
pathogenic microbes utilise type  secretion systems (T3SS) in order to insert virulence 
factors into infected eukaryotic cells, where they subsequently hijack cell-signalling apparatus. 
Furthermore, enteric human pathogens are able to colonise the gut mucosa by way of attaching 
and effacing (A/E) lesions. In general, A/E lesions are characterised by intimate bacterial 
attachment to the apical plasma membrane, localised accumulation of F-actin, and effacement 
of brush border microvilli. In addition, the ability of pathogens to generate A/E lesions is 
dependent upon the presence of the locus of enterocyte effacement (LEE). The LEE represents 
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a genomic pathogenicity island which bears the information required for the formation of a 
T3SS, regulators, chaperones, and effector proteins (Cepeda-Molero et al., 2017). 
 
The configuration of the a T3SS bears a resemblance to a “molecular syringe”, which enteric 
E. coli can utilise to insert effector proteins, such as the translocated intimin receptor (Tir), 
directly into the cytoplasm of target cells. Tir is inserted in the cytoplasmic membrane in a 
particular arrangement which promotes interaction of its central domain with intimin; a 
bacterial cell surface protein, thus facilitating an attachment between the bacterial cell and the 
eukaryotic cell. Furthermore, proteins associated with the regulation of cytoskeletal 
arrangement are recruited by EspFu; a secreted bacterial effector protein. The aforementioned 
proteins include Wiskott-Aldrich (N-WASP); an actin nucleation-promoting factor, and insulin 
receptor tyrosine kinase substrate p53 (IRSp53). Ultimately, this induces the deposit of actin 
beneath attached bacteria, thereby generating the characteristic pedal-like architecture (Nguyen 
& Sperandio, 2012). 
 
 
Staphylococcus Aureus 
 
S. aureus exists as both a human pathogen and a commensal bacterium, with approximately 30 
% of the population colonised by S. aureus. Furthermore, S. aureus is the foremost cause of 
bacteraemia and infective endocarditis. In addition, S. aureus is associated with a wide-range 
of skin and soft tissue infections; ranging from benign to life-threatening. Moreover, S. aureus 
represents the most common pathogen that is extracted from surgical site infections, cutaneous 
abscesses, and purulent cellulitis. (Tong, Davis, Eichenberger, Holland & Fowler, 2015). 
 
S. aureus entering the skin stimulates the arrival of neutrophils and macrophages to the site of 
infection. However, S. aureus has an astounding arsenal of evasive techniques, such as 
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inhibiting chemotaxis of leukocytes, sequestering host antibodies, concealment via generating 
a polysaccharide capsule, or producing biofilm in order to avoid detection by the immune 
system, and withstanding destruction after ingestion by phagocytosis (Tong et al., 2015). 
Receptors situated on the surface of neutrophils play a significant role in the recognition of 
bacteria by way of stimulating phagocyte chemotaxis and activation. In addition, S. aureus 
produces a molecule called chemotaxis inhibitory protein of S. aureus (CHIPS); a secreted 
molecule that inhibits receptor-mediated recognition of pattern-associated molecular patterns 
(PAMPs), which are molecules secreted by bacteria and crucial for phagocyte detection of 
bacterial invaders. Following ingestion, S. aureus can deploy even more diverse procedures to 
undermine immune responses, such as producing catalase and superoxide dismutase in order 
to neutralise reactive oxygen species (ROS). Furthermore, S. aureus produces a series of 
proteins to combat the oxygen-independent killing aspects of the innate immune responses; 
such aspects include antimicrobial peptides (AMPs). With regards to neutralising the activity 
of cationic AMPs, S. aureus undertakes upregulation of resistance mechanisms, such as the D-
alanylation of teichoic acids and the incorporation of cationic phospholipid lysyl-phosphatidyl 
glycerol into the cytoplasmic membrane. These mechanisms combine to reduce the net 
negative charge of the bacterial surface, thus reducing the binding activity of cationic AMPs 
(DeLeo, Diep & Otto, 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
Biofilms 
 
 
Background 
 
The history of microbiology has largely depicted microorganisms as planktonic, freely 
suspended cells which flourish in nutritionally rich culture media. The discovery of 
microorganisms that are able to adhere to exposed surfaces encouraged supplementary studies 
which revealed that these surface-associated microorganisms displayed a distinctive 
phenotype, with regards to gene transcription and growth rate. Van Leeuwenhoek observed 
microorganisms on the surface of teeth using simple microscopes, thus the discovery of 
microbial biofilms is attributed to Van Leeuwenhoek. Furthermore, these biofilm-associated 
microorganisms demonstrated specific mechanisms for the attachment to a surface, the 
establishment of a community configuration, and detachment from a surface. Moreover, 
applying the confocal laser scanning microscope to examine biofilm ultrastructure and 
analysing the genes associated with cell adhesion have significantly contributed to the 
understanding of biofilms (Donlan, 2002). 
 
A biofilm is an accumulation of microbial cells that are adhered to a surface and encased in a 
matrix of mainly polysaccharide material (Donlan, 2002). In the majority of biofilms, the 
microorganisms represent less than 10 % of the dry mass, whereas the extracellular matrix can 
represent over 90 %. The matrix establishes the platform for the three-dimensional architecture 
of the biofilm; the matrix is responsible for the adhesion to surfaces and cohesion within the 
biofilm. Furthermore, the matrix contributes to the robust interactions between cells by 
immobilising them and retaining them in close proximity. In addition, the matrix also exhibits 
recycling features by retaining all of the components of lysed cells, such as DNA, which can 
be used in horizontal gene transfer (Flemming & Wingender, 2010). Organisms capable of 
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biofilm development are unlike their planktonic counterparts with regards to the genes that are 
transcribed. Moreover, biofilms can develop on a wide assortment of surfaces, such as living 
tissues, medical devices, industrial water system piping, and natural aquatic systems. 
Furthermore, depending on the surface, biofilms demonstrate a variable nature which can be 
demonstrated by scanning electron micrographs. In addition, biofilms associated with water 
systems are composed of corrosion products, clay material, fresh water diatoms, and 
filamentous bacteria. On the other hand, biofilms associated with medical devices are 
configured of single, coccoid organisms and the accompanying extracellular polymeric 
substance matrix (Donlan, 2002). Bacteria encased within a biofilm exhibit elevated resistance 
to antibiotics, disinfectants, and to host immune defence systems. Therefore, the significance 
of biofilms is well acknowledged in medical, environmental, and industrial environments 
(Stepanović et al., 2007). 
 
 
Biofilm Structure  
 
Microbial cells and the associated extracellular polymeric substance (EPS) primarily constitute 
the biofilm entity. In addition, the EPS may represent 50 % to 90 % of the total organic carbon 
of biofilms. Furthermore, the EPS displays variation with regards to physical and chemical 
properties, but is predominately comprised of polysaccharides (Donlan, 2002). The EPS 
generated by microbial cells may comprise of neutral macromolecules, however the majority 
of the macromolecules found in the EPS are polyanionic; this is due to the presence of either 
uronic acids or ketal-linked pyruvate (Sutherland, 2001). In addition, the polyanionic nature of 
these matrices promote association with divalent cations, such as calcium, which increases the 
mechanical stability of a mature biofilm by cross-linking with the polymer strands (Donlan, 
2002). There are two crucial properties concerning the EPS that yield a significant effect on 
the biofilm; first, the primary conformation of the polysaccharides present in the EPS is 
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governed by their structure and composition. For example, the inclusion of 1,3- or 1,4--linked 
hexose residues into the backbone of bacterial EPS yields more rigid structures that are not 
prone to flexibility. Second, the EPS found in the biofilm varies with regards to spatial and 
temporal features, thereby not existing as generally uniform (Donlan, 2002). Leriche, Sibille 
& Carpentier (2000) performed a study using the binding specificity of lectins towards sugar 
moieties in order to characterise and quantify exopolysaccharides produced by bacterial 
biofilms. Furthermore, various bacterial genera were utilised in the assay in order to establish 
whether the application of one lectin is enough to observe biofilm exopolysaccharide 
production over time and to establish which particular strains could be characterised by 
exploiting the binding specificity of lectins. The assay utilised two lectins which recognise the 
most common saccharide units found in biofilm matrices; concanavalin A was employed to 
quantify D-glucose and D-mannose residues. In addition, wheat germ agglutinin was employed 
to quantify N-acetyl-D-glucosamine and N-acetylneuraminic acid. Furthermore, Leriche et al. 
(2000) concluded that different organisms produced differing amounts of EPS and the 
extracellular contents derived from the biofilm increased over time. Increased availability of 
carbon substrates will increase the amount of EPS within the biofilm, although a balance 
between the availability of carbon and the limitation of certain nutrients, such as nitrogen, 
potassium, or phosphate, is essential for the increased production of EPS (Sutherland, 2001). 
 
 
Pseudomonas Aeruginosa Biofilm Formation  
 
P. aeruginosa is an aerobic Gram-negative bacterium capable of causing both community-
acquired and hospital-acquired infections. Additionally, P. aeruginosa is a cause of infection 
in immunocompromised hosts and patients with cystic fibrosis. Furthermore, P. aeruginosa 
has an extensive repertoire of antimicrobial resistance mechanisms, such as multidrug efflux 
pumps, -lactamases, and the ability to downregulate outer membrane porins. In addition, P. 
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aeruginosa utilises various mechanisms of virulence such as the secretion of toxins and the 
ability to generate biofilms (Driscoll, Brody & Kollef, 2007). 
 
Alginate, an extracellular polysaccharide, can be overproduced in some isolates of P. 
aeruginosa. The overproduction of alginate can be attributed to a mutation in the mucA gene, 
thereby allowing alginate biosynthesis to be induced under the influence of the AlgU gene. 
Furthermore, the presence of alginate has been observed to hinder infected host immune 
responses, including the scavenging of free radicals produced by macrophages, generating a 
physical barrier that obstructs phagocytosis, and preventing neutrophil chemotaxis and 
complement activation. In addition, alginate is seemingly instrumental in the formation of 
biofilms associated with P. aeruginosa (Driscoll et al., 2007). 
 
The term ‘biofilm’ is related to the mode of growth exhibited by bacteria that yields a collection 
of microcolonies embedded within a biopolymer matrix and attached to a surface. Furthermore, 
biofilms associated with P. aeruginosa can be found in the airways of patients suffering with 
cystic fibrosis. In addition, while undergoing the procedure of attachment, planktonic cells are 
able to communicate intercellularly using a process known as quorum sensing (Driscoll et al., 
2007). Bacteria utilise the mechanism of quorum sensing in order to perceive the density of the 
surrounding bacterial population and react to this information by regulating various genes. 
Furthermore, the mechanism of bacterial communication within a colony is achieved by the 
production of signalling molecules which are received by receptors situated on the surface of 
bacteria; Gram-negative bacteria produce acylated homoserine lactones, whereas Gram-
positive bacteria often produce oligopeptides. The autoinducer signal molecules, N-(3-
oxododecanoyl) homoserine lactone and N-butyryl homoserine lactone, increase as a 
population of P. aeruginosa increases. As a consequence, an intracellular threshold is attained 
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which stimulates these molecules to bind to and activate their cognate transcriptional regulators 
(Smith & Iglewski, 2003). In biofilm development, P. aeruginosa will generate 
exopolysaccharides which results in the production of a matrix that is characterised by an 
intricate assembly of bacterial microcolonies separated by water channels (Driscoll et al., 
2007). 
 
 
Mechanisms of Biofilm Resistance  
 
It is well established that biofilm-associated cells encased in an exopolysaccharide matrix 
exhibit properties that are distinct from planktonic cells; one of which is an increased resistance 
to antimicrobial agents. In vitro investigations have begun to illuminate the mechanisms 
underlying how and why surface-attached microbial communities display resistance to 
antimicrobial agents. Furthermore, there are multiple resistance mechanisms which vary 
depending upon the species of bacteria and the biocide being applied. In addition, these 
mechanisms include chemical or physical diffusion barriers to antimicrobial compounds, 
reduced biofilm growth rate as a result of nutrient restriction, initiation of general stress 
responses, and the development of a biofilm-specific phenotype (Mah & O’Toole, 2001). 
 
The influence the exopolysaccharide matrix has on the migration of antimicrobial agents to the 
underlying cells varies with the antimicrobial agent being applied. For example, relating to 
antibiotics, it has been demonstrated that by cultivating biofilms associated with P. aeruginosa 
on one side of a dialysis membrane, the amount of piperacillin that can permeate into a biofilm 
can be evaluated. Furthermore, biofilms associated with P. aeruginosa obstruct the passage of 
piperacillin. On the other hand, biofilms associated with S. epidermis allowed the penetration 
of rifampicin and vancomycin across the membrane, thereby indicating that these antibiotics 
had successfully penetrated the biofilm. Additionally, hydrogen peroxide demonstrated 
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invasive behaviour against a thin biofilm-covered bead associated with a low colony-forming 
unit (CFU) count, whereas thicker biofilms demonstrated increased resistance to hydrogen 
peroxide. Intriguingly, a thick biofilm developed by a mutant strain of P. aeruginosa, which 
lacked one of the fundamental catalase genes, katA, was impervious to hydrogen peroxide. 
Furthermore, restriction of antimicrobial compounds to the cells embedded within the biofilm 
can be attributed to a reaction with, or sorption to, the components of the biofilm (Mah & 
O’Toole, 2001). 
 
An increase in resistance can be stimulated by a switch from exponential to slow, or no growth. 
Due to the fact that the cells developing within a biofilm are likely to experience some form of 
nutrient limitation, it has been implied that this physiological alteration can be attributed to the 
resistance of biofilms to antimicrobial agents. Furthermore, by examining the growth rate-
induced effects concerning the planktonic cells and biofilm cells of P. aeruginosa, E. coli, and 
S. epidermis, it was observed that the sensitivities of both types of cells towards ciprofloxacin 
increased with increasing growth rate. In addition, concerning P. aeruginosa, it was observed 
that as the growth rate increased, the planktonic cells demonstrated more susceptibility than 
biofilm cells to ciprofloxacin. Additionally, studies have analysed the resistance associated 
with planktonic and biofilm cells as they transition from exponential growth into stationary 
growth. Moreover, the results obtained established that resistance increased as both types of 
cells transitioned into the stationary phase of growth, with biofilm cells exhibiting 15-times 
more resistance than planktonic cells (Mah & O’Toole, 2001). 
 
An emerging concept associated with biofilm resistance is that a biofilm-specific phenotype is 
stimulated in a subpopulation of the community to help suppress the adverse effects of 
antimicrobial agents by the expression of active mechanisms. In addition, this resistance-linked 
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phenotype might be stimulated by nutrient limitation, particular types of stress, high cell 
density, or a combination of the aforementioned factors. Furthermore, phenomena such as 
multidrug efflux pumps, which are capable of expelling chemically unrelated antimicrobial 
agents from the cell, could be related to the development of resistance to antimicrobial 
compounds. The generation of a multidrug-resistant phenotype in E. coli is stimulated by 
upregulation of the mar operon. As well as multidrug efflux pumps, the membrane-protein 
composition can be subjected to alterations, thereby leading to changes in cell permeability 
when exposed to antimicrobial compounds. Moreover, mutations in regulatory genes, such as 
ompB, which is responsible for encoding outer membrane porin proteins, enhanced the 
resistance of E. coli to -lactam antibiotics. With regards to outer membrane porins, it has been 
demonstrated that biofilm-associated bacteria exhibit elevated expression levels of ompC, an 
outer membrane protein, and other osmotically regulated genes compared with planktonic 
bacteria. Furthermore, its plausible that the environmental conditions within a biofilm are 
linked with elevated osmotic stress, thereby resulting in alterations concerning the cell 
envelope that afford the bacteria protection from the adverse effects of antimicrobial 
compounds (Mah & O’Toole, 2001). 
 
Moreover, there are a variety of mechanisms that promote resistance against antimicrobial 
compounds; mechanisms which depend upon the bacterial complement of the biofilm and the 
antimicrobial compound being applied to eradicate the biofilm. Such mechanisms include the 
development of a heterogenous population of cells, thereby giving rise to varying levels of 
resistance throughout the population. For example, the cells situated in close proximity to the 
liquid-biofilm interface might be inaccessible, to a small extent, by the generation of enzymes 
from the exopolysaccharide matrix which neutralise antimicrobial compounds. In addition, the 
cells situated in an intermediate position might exhibit slow growth and might benefit from 
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protection from the outermost cells. To conclude, another sub-population of cells might be 
stimulated by environmental alterations to express a biofilm-specific resistance phenotype 
(Mah & O’Toole, 2001). 
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Antimicrobials  
 
 
Background 
 
In the present day, vigilant hand-washing practices are encouraged to reduce the spread of 
bacteria from person to person and ultimately prevent the rise of infections within individuals. 
Ironically, persistent hand-washing practices can produce undesired side effects, especially in 
the healthcare environment where strict guidelines encourage methodical hand-washing 
practices (Moadab, Rupley & Wadhams, 2001). In order to maintain the lowest possible 
microbial counts during surgical procedures, surgical hand scrubbing practices are applied in 
pre-surgical preparations to remove microorganisms from the hands and forearms. In the event 
of accidental damage to a surgical team member’s glove during surgery, effective hand 
scrubbing minimises the patient’s risk of acquiring a postoperative infection (Paulson, 1994). 
Contact dermatitis, as well as other skin problems, is connected with routine hand-washing 
practices and wearing gloves. Healthcare workers with impaired skin can facilitate the 
transmission of larger numbers of bacterial pathogens compared with healthcare workers with 
undamaged skin. Additionally, patients with dermatological problems are more likely to be 
subjected to skin colonisation by organisms such as Staphylococcus Aureus (Larson et al., 
1998). Undamaged skin provides the body with protection against environmental pathogens; 
the skin is comprised of the epidermis and the dermis. In addition, the squamous stratified 
epithelium of the epidermis is compiled of five distinctive layers of cells. Furthermore, the 
body’s internal and external environment are separated by the epidermis. As a consequence of 
compromised skin, the underlying tissue becomes exposed which greatly increases the risk of 
infection (Gould, 2012). Consequently, the use of rinse-free hand sanitisers has increased, 
which are used alongside proper hand-washing techniques with soap and water. Additionally, 
gels and foams represent the most widely used hand sanitisers, which use alcohol as the 
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principal antimicrobial agent. The popularity of these rinse-free sanitisers is chiefly based on 
aspects such as cost, inclusion of emollients, fragrances, delivery vehicle, size, and marketing. 
In addition, the rationale behind the selection of alcohol-based sanitisers rarely includes the 
products effectiveness at eradicating bacteria after a single use (Dyer, Gerenratch & Wadhams, 
1998). As well as being prominently utilised in healthcare environments in the form of 
antiseptics and disinfectants, they are also widely employed by the general public due to 
increasing concerns regarding the potential for microbial contamination in the food and general 
consumer markets. Furthermore, an extensive range of active chemical agents, or biocides, can 
be found in these products; many of which have been associated with antimicrobial activity for 
hundreds of years. In general, biocides are recognised as possessing a broader spectrum of 
activity than antibiotics, while antibiotics are associated with having specific intracellular 
targets (McDonnell & Russell, 1999). Furthermore, the overall effectiveness of an 
antimicrobial agent can be subdivided into three categories; the immediate antimicrobial 
efficacy, the persistent effectiveness, and the residual antimicrobial efficacy. The immediate 
antimicrobial efficacy relates to the quantitative measurement of both the mechanical and 
immediate inactivation of microorganisms on the surfaces of the skin. The persistent 
antimicrobial effectiveness relates to the quantitative measurement of a topical antimicrobials 
capacity to prevent the occurrence of microbial recolonisation of the skins surface following 
the application of the product. In addition, the prevention of microbial recolonisation can be 
achieved by either microbial inhibition or eradication. The residual antimicrobial efficacy is 
defined as the measurement of a products cumulative abilities after it has been employed for a 
period of time. Furthermore, certain antimicrobial agents are absorbed into the stratum 
corneum of the skin following prolonged use, thus inhibiting bacterial recolonisation on the 
surface of the skin (Paulson, 1994). 
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The mechanisms involved in the action of antiseptics and disinfectants against bacteria has 
received considerable attention, thus yielding significant progress in the understanding of 
antimicrobial modes of action. Regardless of cell type, it is likely that there is a common 
sequence of events with respect to the mechanisms of antimicrobial action. Moreover, this 
sequence of events can be envisaged as an initial interaction of the antimicrobial compound 
with the cell surface, subsequent permeation into the cell, and action at the target site. In 
addition, cell viability can be significantly affected by interaction at the cell surface, however 
the majority of antimicrobial agents deliver their effects intracellularly. Furthermore, the 
outermost layers of microbial cells can significantly influence whether microbial cells will be 
susceptible or insusceptible to antimicrobial compounds (McDonnell & Russell, 1999). 
 
 
Alcohol 
 
The most common alcohols employed in antimicrobial formulations are ethyl alcohol, 
isopropyl alcohol, and n-propanol. Alcohol exhibits rapid broad-spectrum activity against 
vegetative bacteria, viruses, and fungi. Despite its inability to eradicate spores, alcohol is 
known to inhibit the growth of spores and the germination of spores. As a consequence, alcohol 
is widely utilised in hard-surface disinfection and skin antisepsis. In essence, the mode of action 
regarding alcohol is thought to involve damage to the membrane integrity, rapid denaturation 
of intracellular materials, such as proteins, followed by obstruction of metabolic processes and 
eventual cell lysis (McDonnell & Russell, 1999). Succinic acid dehydrogenase, an enzyme 
present in many species of bacteria, such as E. coli, is able to extract hydrogen from a variety 
of substrates. Furthermore, succinic acid dehydrogenase is prone to denaturation when exposed 
to alcohol (Sykes, 1939). Studies conducted by Sykes (1939), using methylene blue as a redox 
indicator to monitor the enzymatic activity of succinic acid dehydrogenase, concluded that 
various aliphatic monohydric alcohols were capable of comprehensively incapacitating the 
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enzyme. Alcohol is proven to produce adverse effects against the skin as it removes sebum and 
lipids that protect the skin from bacterial infections. Moreover, a study conducted by Dyer et 
al. (1998) on the efficacy of various hand-wash formulae on human subjects revealed, despite 
all alcohol-containing products exhibiting potent antimicrobial activity, that all subjects who 
completed the test protocol using alcohol-based hand sanitiser formulae reported palmar pain 
or discomfort. In addition, following detailed assessment, these subjects were discovered to 
have noticeable swelling that was, in some cases, supplemented by erythema of the palmar 
tissues. Furthermore, persistent use of hand sanitisers containing alcohol promotes the skins 
vulnerability to infection by transient pathogenic bacteria. In the healthcare environment, these 
circumstances can promote the spread of disease-causing bacteria (Dyer et al., 1998). 
Therefore, the development of alcohol-free formulae is essential to reducing the spread of 
disease and protecting the natural barrier functions of the skin. 
 
 
Chlorhexidine 
 
Belonging to a class of compounds known as biguanides, chlorhexidine is probably the most 
widely used biocide in antiseptic products, specifically in hand-wash formulae and oral 
products. Its widespread inclusion in various biocide formulae is attributed to its broad-
spectrum efficacy, substantivity for the skin, and low irritation (McDonnell & Russell, 1999). 
Chlorhexidine comprises of two cationic groups separated by a hydrophobic hexamethylene 
bridging structure, consequently it is categorised as a cationic antimicrobial agent which 
exhibits activity towards Gram-positive and Gram-negative bacteria. In general, cationic 
antimicrobial agents interact strongly with bacterial cells due to the presence of a net negative 
charge on the outermost surface of the cell. Following strong association with the anionic sites, 
particularly acidic phospholipids and proteins situated on the surface of bacterial cells; 
osmoregularity, metabolic catabolism of the cell membrane, and membrane-associated 
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enzymes are affected. As a consequence, leakage of cellular materials occurs, such as 
potassium ions, as well as inhibition of respiration (Gilbert & Moore, 2005). Early work 
proposed that the growth inhibitory effects of chlorhexidine were linked with its ability to 
impede the activities of membrane-bound ATPase. However, this mode of action has since 
been disregarded as the concentrations required to yield such effects are substantially greater 
than those likely to be deployed in vivo (Chawner & Gilbert, 1989). Studies conducted by 
Barrett-Bee, Newboult & Edwards (1994) revealed that the application of chlorhexidine 
inhibited oxygen uptake by bacteria, such as E. coli and P. aeruginosa, hence triggering a 
reduction in ATP levels. However, Barrett-Bee et al. (1994) concluded that the primary 
antimicrobial action of chlorhexidine was its ability to interfere with the function of cellular 
membranes. Furthermore, studies performed by Barrett-Bee et al. (1994) revealed that the 
application of chlorhexidine triggered the release of -lactamase from the periplasmic space of 
Gram-negative bacteria, which signifies damage to the integrity of the outer membrane of 
Gram-negative bacteria. -lactamase is responsible for promoting antibiotic resistance in 
Gram-negative bacteria against -lactam antibiotics, thus repeated exposure to -lactam 
antibiotics has generated dynamic and continuous mutations in -lactamases. In addition, -
lactamase is able to exert its resistance mechanisms against hydrolytically susceptible chemical 
bonds in antibiotics, thus weakening the activity of antibiotics (Shaikh, Fatima, Shakil, Rizvi 
& Kamal, 2015). Chlorhexidine and quaternary ammonium compounds (QACs) share a similar 
mode of action, however the hydrophobic regions of QAC biocides are prone to solubilisation 
within the hydrophobic core of the cell membrane, whereas those of chlorhexidine are not. In 
addition, being six carbons in length, the hydrophobic region of chlorhexidine is able to 
integrate into the lipid bilayer by means of folding, therefore chlorhexidine disrupts the bilayer 
by bridging between pairs of adjacent phospholipid head groups and dislodging the associated 
divalent cations. Furthermore, the distance between phospholipid head groups within a 
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monolayer approximately corresponds to the length of the hexamethylene group in 
chlorhexidine (Gilbert & Moore, 2005). Loss off membrane fluidity is a consequence of the 
interaction between chlorhexidine and the phospholipids within the bilayer. Furthermore, the 
effects of such an interaction can manifest itself into cellular leakage of potassium ions and 
protons (Elferink & Booij, 1974). 
 
When deployed in a domestic environment, antimicrobial agents are incorporated into 
formulations alongside several excipients that may serve to increase the overall potency. 
Antimicrobial formulations are applied across a variety of settings which include healthcare 
and industrial environments, where their purpose includes pharmaceutical product preservation 
and hard-surface disinfection. Furthermore, biocides can be included in medical device 
coatings, such as sutures, wound dressings, and urinary catheters for the purpose of preventing 
bacterial adhesion which may lead to the production of robust biofilms (Cowley et al., 2015). 
The universal application of antimicrobial compositions illustrates how important the 
regulation of bacterial populations, among other microorganisms, inhabiting the skin is to 
consumers. Understandably, antimicrobial compositions must be able to significantly decrease 
populations of different microorganisms swiftly, although without demonstrating harmful 
effects against the skin. Typical antimicrobial cleansing formulae contain an active 
antimicrobial agent, a surfactant, and various other ingredients such as fragrances. In addition 
to all the components being possibly retained within an aqueous carrier, pH adjusters may be 
incorporated into antimicrobial formulae. 
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Figure 3. The molecular structure of chlorhexidine. 
 
 
Quaternary Ammonium Compounds 
 
Quaternary ammonium compounds (QACs) can be incorporated alongside chlorhexidine into 
antimicrobial formulations to serve primarily as surfactants, as well as demonstrating 
antimicrobial properties. QACs are examples of cationic surfactants; named accordingly due 
to the presence of a positive charge on the hydrophilic portion of their molecular structure. 
Furthermore, QACs are composed of two chemically distinct regions within their molecular 
structure; a hydrophobic group and a hydrophilic group (McDonnell & Russell, 1999). As a 
result of their amphiphilic nature, QACs are incorporated into various cosmetic and personal 
care products. Within these product formulations, they are utilised for their surfactant, 
preservative, and antimicrobial properties. Furthermore, QACs exhibit a detergent-like 
mechanism of action when interacting with microbial life, as a consequence of their 
hydrophobic and hydrophilic components. In general, electrostatic interactions between the 
positively charged QAC head and the negatively charged bacterial membrane are followed by 
penetration of the QAC side chains into the intramembrane region. Diffusion into the 
intramembrane region triggers leakage of cytoplasmic materials followed by cellular lysis. In 
addition, the additional outer membrane associated with Gram-negative bacteria reduces the 
antibacterial activity of QACs, whereas the lack of an outer membrane in the structure of Gram-
positive bacteria increases their susceptibility to the antimicrobial activity of QACs (Jennings 
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et al., 2015). Low QAC concentrations interact strongly with anionic sites located on the 
membrane surface, thus instigating the suppression of osmoregulatory capabilities; triggering 
the discharge of potassium ions and protons. Intermediate concentrations disrupt membrane-
situated cellular processes, such as respiration, solute transport, and cell wall biosynthesis. 
High concentrations, used in many biocidal formulations, eradicate cells as a consequence of 
the solubilisation of their membranes, thus triggering the release of all cellular contents (Gilbert 
& Moore, 2005). 
  
Figure 4. Alkyldimethylbenzylammonium (ADBAC) chlorides represent a mixture of 
ADBACs where n = 8, 10, 12, 14, 16, and 18. 
 
 
Figure 5. The molecular structure of didecyldimethylammonium chloride (DDAC). 
 
 
Silver 
 
The antimicrobial properties demonstrated by silver against a broad range of microorganisms 
has been acknowledged since ancient times. Presently, silver is deployed to regulate the growth 
of bacteria in a variety of medical applications, such as dental work, catheters, and the healing 
of burn wounds (Jung et al., 2008). For antimicrobial applications, commonly used silver 
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compounds are silver sulfadiazine, silver nitrate, and silver acetate. Furthermore, the 
interaction of silver with thiol groups represents its antimicrobial mechanism of action. 
Moreover, it has been suggested that bacterial inactivation is instigated by the interaction of 
silver with thiol groups in enzymes and proteins. In addition, it has been proposed that silver 
salts exert their antimicrobial effects by binding to key functional groups in fungal enzymes. 
Silver ions trigger the discharge of potassium ions from microorganisms, thus the cytoplasmic 
membrane, which many enzymes are linked with, represents a significant target site for the 
antimicrobial activity of silver ions. Furthermore, silver ions instigate structural abnormalities 
within cells of P. aeruginosa; affected cellular constituents are the cytoplasmic membrane, 
cytoplasmic contents, and outer cell layers. In addition, silver ions interact with the bases in 
the structure of DNA in order to exert lethal action (McDonnell & Russell, 1999). 
 
Jung et al. (2008) conducted a study concerning the antimicrobial activity of the silver ion 
against Staphylococcus aureus and Escherichia coli. In addition, the mechanism of action of 
the silver ion was also investigated. Furthermore, transmission electron microscopy (TEM) 
analysis showed S. aureus cells undergoing lysis, thereby resulting in the discharge of their 
cellular contents, when exposed to a silver ion solution for 2 hours. In contrast, S. aureus cells 
that had not been exposed to a silver ion solution displayed their normal coccal morphology, 
uniform distribution with regards to electron density within the cytoplasm, intact cell 
membranes, and cell walls displaying a structurally intact peptidoglycan layer. In addition, S. 
aureus cells treated with a silver ion solution exhibited impaired walls, impaired membranes, 
and uneven electron distribution within the cytoplasm. Concerning E. coli cells that had not 
been treated with a silver ion solution, Jung et al. (2008) reported no alterations with regards 
to their normal morphology, with their flagella and fimbriae undamaged. However, E. coli cells 
that had been subjected to a silver ion solution exhibited abnormal morphology. In addition, 
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TEM analysis of treated E. coli cells revealed either localised or complete separation of the cell 
membrane from the cell wall. 
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Antimicrobial Susceptibility Testing 
 
 
Overview 
 
Clinical microbiology laboratories employ antimicrobial susceptibility testing to determine the 
effectiveness of prospective antimicrobial agents, or to identify bacterial isolates demonstrating 
resistance (Jorgensen & Ferraro, 2009). Antimicrobial susceptibility testing can be applied in 
drug discovery, epidemiology, and prediction of therapeutic outcome. The rise of antimicrobial 
resistance to antibiotics is a growing concern; increased resistance decreases the efficacy of 
important groups of antibiotics, such as tetracyclines and cephalosporins. As a consequence of 
rising antimicrobial resistance, the development of novel antibiotics is essential and demands 
suitable procedures to determine their antimicrobial potency. Natural products such as plants, 
prokaryotic bacteria, eukaryotic microorganisms, and various animal organisms represent the 
major sources of new drug molecules today. However, when reviewing published articles 
examining the antimicrobial efficacy of potential antimicrobial agents, it is difficult to compare 
different sets of results due to the application of diverse, non-standardised approaches with 
regards to inoculum preparation techniques, inoculum size, growth medium, incubation 
conditions, and end points determination. Furthermore, a variety of laboratory methods can be 
employed to assess the in vitro antimicrobial activity of potential antimicrobial compounds. 
The disk diffusion assay represents one of the most elementary antimicrobial susceptibility 
methods currently employed today. In addition, in order to obtain more conclusive information 
concerning the time-dependent or concentration-dependent effects of antimicrobial agents, 
time-kill studies can be applied. Furthermore, flow cytofluorometric methods can illuminate 
the extent of cellular damage imposed upon a microorganism (Balouiri, Sadiki & Ibnsouda, 
2016). 
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Preparing dilutions of antimicrobial agents in order to obtain minimum inhibitory 
concentrations (MICs) is crucial for providing reference values for antimicrobial susceptibility 
testing. Furthermore, MICs are used in resistance surveillance, evaluating similarities between 
new agents, determining the susceptibility of organisms that generate ambiguous results in disk 
assays, further evaluation of organisms where the disk assay may be fallacious, and when 
quantitative results are required for clinical management. Dilution tests involve evaluating an 
organism’s ability to produce visible growth on a series of agar plates, or in broth, containing 
dilutions of the antimicrobial agent. Furthermore, the minimum inhibitory concentration (MIC) 
can be defined as the lowest concentration of an antimicrobial agent that inhibits visible growth 
of a microorganism within a specified time period and under defined in vitro conditions. MIC 
data influences the chosen course of action taken by a clinician with regards to treatment 
decisions, as they provide information about the susceptibility of an organism to various 
antimicrobial agents. However, reproducibility between different laboratories demands careful 
control and standardisation due to the fact that different methods may significantly affect the 
results yielded (European Committee for Antimicrobial Susceptibility Testing, 2003). 
 
In the clinical environment, MIC values can be used to categorise microorganisms as either 
clinically susceptible, intermediate, or resistant to the tested antimicrobial agent. The advisory 
standards for these groupings are published by different national organisations, such as the 
Clinical and Laboratory Standards Institute (CLSI) in the USA and the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST) (Wiegand, Hilpert & Hancock, 2008). 
 
The skin concentrate formula provided by Crystal Clear Limited was subjected to antimicrobial 
evaluation in accordance with the European standard BS EN 1276. The experimental procedure 
required by the standard is referred to as a quantitative suspension test. Scientific literature 
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does contain experimental procedures with regards to the quantitative suspension test. Müller 
& Kramer (2008) have outlined an experimental procedure for the quantitative suspension test. 
Despite the procedure not being an exact duplicate of the procedure outlined by the standard, 
the procedure does share a near identical design in order to achieve log reduction values. Log 
reduction values are quantitative measurements which outline what percentage of bacteria are 
eradicated during the course of the test. In general, a bacterial suspension of a known 
concentration, in colony-forming units per millilitre (CFU/mL), is prepared. From the 
suspension, an aliquot is transferred into fresh cell culture medium containing a test compound. 
Organisms in the suspension are exposed to the test compound for a pre-determined amount of 
time and at a pre-determined temperature. Following the appropriate contact time, an aliquot 
of the test combination is extracted and the bactericidal activity of the test compound is 
neutralised by a chosen compound, either alone or in combination with another compound. 
Following an appropriate time of inactivation, the number of viable cells is determined by way 
of preparing serial dilutions in fresh broth, followed by plating an appropriate amount of each 
dilution on agar, and incubating the agar plates for a pre-determined duration. Once the number 
of viable cells, in CFU, is obtained, the reduction in viability can be obtained (Müller & 
Kramer, 2008). 
 
 
Disk Diffusion Assay 
 
The disk diffusion assay is routinely employed for antimicrobial susceptibility testing and 
represents the official method used in many clinical microbiology laboratories. The disk 
diffusion assay involves inoculating agar plates with a standardised inoculum of a test 
microorganism. Following inoculation, paper disks containing the test compound are deposited 
onto the agar surface and the agar plates are incubated in appropriate conditions for a specified 
time duration. Essentially, the test compound disseminates into the agar and prevents the 
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growth of the microorganism on solid media. Furthermore, the diameter of growth inhibition 
generated by the test compound around the disk is measured. Both EUCAST and the CLSI 
have published a set of standards which dictate the type of growth media to use, the 
temperature, the period of incubation, and the required inoculum size. The standards comprised 
by the CSLI recommend using Mueller-Hinton agar and an inoculum size of 1-2 x 108 CFU/mL, 
which is equivalent to the 0.5 McFarland standard. Additionally, the incubation temperature 
required is 35  2 C and the incubation time duration is 16-18 hours (Balouiri et al., 2016). 
 
The inhibition of growth produced by an antimicrobial agent in the disk diffusion assay does 
not signify bacterial death, hence this method cannot differentiate between bactericidal and 
bacteriostatic effects. Additionally, the MIC cannot be established using the disk diffusion 
method as it is unachievable to quantify the amount of antimicrobial agent that has dispersed 
into the agar medium. Nonetheless, the disk diffusion assay provides numerous advantages 
over other antimicrobial susceptibility methods, such as the low cost associated with the assay, 
the simplicity involved in performing the assay, and the straightforward analysis of results. 
Furthermore, the capacity of the disk diffusion assay to evaluate a substantial number of 
microorganisms and antimicrobial agents represents another advantage (Balouiri et al., 2016). 
 
 
Dilution Methods 
 
Dilution methods represent the most appropriate methods for establishing MIC values as they 
allow the concentration of antimicrobial agents to be estimated in agar or broth medium. Broth 
and agar dilution methods allow quantitative analysis of the in vitro behaviour of antimicrobial 
agents against bacteria (Balouiri et al., 2016). However, the MIC value obtained using dilution 
methods does not consistently relate to an absolute value, since the actual MIC value will 
represent a point between the lowest test concentration that inhibits bacterial growth and the 
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next lowest concentration (Patel, 2012). Numerous sanctioned guidelines exist for dilution 
antimicrobial susceptibility testing against fastidious and non-fastidious bacteria. Furthermore, 
the standards comprised by EUCAST and the CLSI provide standardised procedures for 
evaluating antimicrobial agents that are practical to apply in the majority of clinical laboratories 
(Balouiri et al., 2016). 
 
 
Broth Dilution Method 
 
The tube dilution method represents one of the earliest antimicrobial susceptibility testing 
methods. The method involves preparing a series of two-fold dilutions of test compound and 
distributing them into individual test tubes. Each dilution of antimicrobial agent is tested 
against a suspension of bacteria containing 1-5 x 105 CFU/mL. Following incubation, 
monitoring differences in turbidity is used to differentiate varying degrees of bacterial growth. 
The tube dilution method provides a quantitative result in the form of the MIC, although it does 
offer many disadvantages including the tedious task of preparing dilutions, the likelihood of 
errors while preparing dilutions, the copious amounts of reagents required for the assay, and 
the necessity for a large workstation to accommodate the practical procedures (Patel, 2012). 
 
In an effort to make the broth dilution method more practical, the test can be conducted in 
small, disposable plastic trays. The miniaturisation and mechanisation of the test allowed up to 
twelve different agents, of as little as 100 L, to be evaluated in a range of eight two-fold 
dilutions in a single 96-well plate. The typical clinical microbiology laboratory utilises a 
mechanical dispensing device to aliquot precise volumes of diluted test agent into the 
individual wells of a plate from large volume vessels. Similar to the tube dilution method, each 
well of the plate is inoculated with a standardised suspension of bacteria. Following incubation 
overnight without agitation, multiple MICs are established using a manual or automated 
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viewing apparatus in order to examine each individual well for growth simultaneously 
(Jorgensen & Ferraro, 2009). MIC values can be affected by the size of the inoculum, the type 
of growth medium used, the incubation time, and the method employed to prepare the 
inoculum. Therefore, the CLSI and EUCAST have both issued approved standardised 
guidelines for the broth dilution assay. Additionally, both sets of guidelines are very similar in 
terms of methodology, with differences associated with inoculum preparation and inoculum 
size. Furthermore, EUCAST guidelines recommend employing spectrophotometric means in 
order to ascertain MIC values. CLSI guidelines recommend using Mueller-Hinton broth as the 
growth medium, using an inoculum size equivalent to the 0.5 McFarland standard, and 
incubating the plates for 18 hours in an incubator set at 35 C (Balouiri et al., 2016). 
 
The main advantages associated with the microdilution method include the reduced amounts 
of reagents and space required due to the miniaturisation of the assay. In addition to using 
spectrophotometric means to examine wells for bacterial growth, colorimetric methods can be 
employed which act as visual aids in distinguishing between wells exhibiting bacterial growth 
and wells not exhibiting bacterial growth. Colorimetric methods utilise dye reagents which act 
as growth indicators in microdilution methods, such as the resazurin dye (Balouiri et al., 2016). 
Resazurin permeates cells and serves as a redox indicator that can be utilised to measure viable 
cell number. Furthermore, resazurin is converted to resorufin by viable cells which is 
characterised by a fluorescent, pink colour. In addition, the general disadvantage of using 
resazurin to monitor cell viability includes the necessity to incubate the substrate with viable 
cells at 37C for a suitable time period in order to generate a signal; incubation increases the 
probability of artefacts being chemically produced from interactions among assay chemistry, 
the compounds being assayed, and the biochemistry of the cell (Riss et al., 2013). Furthermore, 
establishing the minimum bactericidal concentration (MBC) represents the most common 
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means of measuring the bactericidal activity of antimicrobial agents. The MBC is defined as 
the lowest concentration of antimicrobial agent required to kill 99.9% of the inoculum after a 
24-hour time period in incubation under a standardised set of conditions. Furthermore, 
following the acquirement of the MIC value, the MBC can be obtained by sub-culturing from 
wells displaying no visible indicators of bacterial growth on non-selective agar plates to 
establish the number of surviving cells (CFU/mL) after a further 24-hour incubation period 
(Balouiri et al., 2016). 
 
Figure 6. The conversion of resazurin to the fluorescent, pink resorufin product by viable cells. 
NADH is oxidised to NAD+ alongside the conversion. 
 
 
Agar Dilution Method 
 
The agar dilution method entails supplementing molten agar medium with varying 
concentrations of antimicrobial agent, typically using serial two-fold dilutions, followed by the 
application of a standardised bacterial inoculum to the surface of the agar medium (Patel, 
2012). The MIC endpoint in the agar dilution method is defined as the lowest concentration of 
antimicrobial agent that completely inhibits bacterial growth under appropriate incubation 
conditions. Furthermore, antimicrobial agents can react with liquid medium in the broth 
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dilution method which hinders the detection of bacterial growth. As a consequence, the agar 
dilution method is often preferred to the broth dilution method in establishing the MIC 
(Balouiri et al., 2016). An additional advantage of the agar dilution method includes the 
possibility of evaluating multiple strains of bacteria on the same set of agar plates 
simultaneously. A disadvantage of the agar dilution method include it requiring significant 
economic and technical resources if the assay is not automated. Additional disadvantages are 
the necessity to use agar plates within one week of preparation and the difficulty of confirming 
the purity of the inoculum due to the persistent risk of contamination (Patel, 2016). 
 
 
Biofilm Quantification  
 
The in vitro investigation of biofilm formation and development over the last decades has 
generated a wide-ranging series of model systems. Furthermore, the majority of these model 
systems quantify biofilm biomass by employing traditional plating methods which are 
laborious and time-consuming. Alternative assays can be categorised into biofilm biomass 
assays, viability assays, and matrix quantification assays (Peeters, Nelis & Coenye, 2007). 
Bacteria associated with biofilms demonstrate elevated resistance to antibiotics, disinfectants, 
and host immune defences. Therefore, the significance of biofilms is appropriately 
acknowledged in medical, environmental, and industrial environments (Stepanović et al., 
2007). 
 
Crystal violet staining represents a well-documented technique for the quantification of biofilm 
biomass in a 96-well, flat-bottomed plate. Furthermore, crystal violet staining was first 
described by Christensen et al. (1985) to assess the adherence of coagulase-negative 
staphylococci to plastic tissue cell culture plates; subsequent modifications to the technique 
have increased its accuracy by allowing biofilm biomass quantification to be measured in the 
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entire well (Peeters et al., 2007). In brief, the method involves plating cultures of coagulase-
negative staphylococci in fresh Trypticase soy broth (TSB) following an appropriate growth 
period. Following an appropriate incubation period, the microorganisms that have attached to 
the plate are fixed in place before being stained by the application of crystal violet dye, whereas 
any non-adherent cells are discarded appropriately. Following the application of crystal violet 
dye, the optical densities of the stained bacterial cells are recorded at a wavelength of 570 
nanometres (nm). Furthermore, the results obtained are used to categorise bacteria into non-
adherent, weakly adherent, and strongly adherent (Christensen et al., 1985). 
 
The advantages of the assay described by Christensen et al. (1985) include it being inexpensive 
and straightforward to perform. Furthermore, the crystal violet assay is routinely employed for 
the quantification of biofilms generated by a broad range of microorganisms (Peeters et al., 
2007). However, crystal violet dye does not stain the slimy material characterised by acid 
mucopolysaccharides, thus crystal violet dye is inadequate for indicating the presence of slimy 
material. Furthermore, Alcian blue can be employed to indicate the presence of slimy material 
as it selectively stains acid mucopolysaccharides (Stepanović et al., 2007). 
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Biocompatibility 
 
In the healthcare setting, healthcare professionals are constantly exploring new ways to 
optimise treatments for difficult-to-heal wounds. Additionally, exposed wounds, particularly 
in diabetic and immunosuppressed patients, are prone to invading pathogens. Invading 
pathogens lead to bacterial colonisation which is associated with delayed healing and triggers 
severe morbidity, such as multi-organ failure. Therefore, topical antiseptics play a key role in 
the treatment of wounds (Hirsch et al., 2010). Antiseptics are substances with anti-infective 
properties that, following topical application, eradicate or inhibit the growth of microorganisms 
in or on living tissue. In addition, to inhibit the development of bacterial resistance, antiseptics 
are applied at concentrations considerably higher than their maximum bactericidal 
concentrations (MBCs). However, antiseptic preparations should not exert toxic effects on host 
tissues. Additionally, antiseptics should be consistent with the concept of biocompatibility of 
medical products, which states that antiseptics should not impair healing processes (Müller & 
Kramer, 2008). Therefore, it is important to evaluate potential cytotoxicity of antiseptics as 
they are routinely administered on human skin for therapy (Hirsch et al., 2010). Chlorhexidine 
digluconate is well established as a potent antimicrobial agent and its application as an 
antiseptic is firmly recognised as the gold standard. However, despite chlorhexidine 
digluconates substantial bactericidal capabilities against a wide-ranging variety of bacteria, 
evidence has emerged indicating that chlorhexidine digluconate demonstrates adverse effects 
on mammalian tissues and cells (Giannelli, Chellini, Margheri, Tonelli & Tani, 2008). 
 
Giannelli et al. (2008) conducted an in vitro study concerning the effect of chlorhexidine 
digluconate on different cell types; osteoblastic Saos-2 derived from osteosarcoma cells, 
murine fibroblasts, and murine endothelioma H-end cells. With regards to cell viability, studies 
concluded that the concentration of chlorhexidine digluconate contributed to its effect on cell 
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viability. In addition, the impact of chlorhexidine digluconate on cell viability was time-
dependent. Furthermore, Saos-2 cells demonstrated elevated sensitivity towards chlorhexidine 
digluconate, since their viability was substantially decreased by approximately 57.5 % after 
exposure to 0.01 % chlorhexidine digluconate for 1 minute. In addition, confocal microscopy 
confirmed significant disruption to the cytoskeletal organisation, thereby resulting in cell 
growth arrest and apoptosis. Furthermore, Giannelli et al. (2008) investigated the apoptosis-
inducing activity of chlorhexidine digluconate. It was concluded that following 1 minute of 
exposure to 0.01 % chlorhexidine digluconate, 30 % of Saos-2 cells displayed apoptotic nuclei. 
Additionally, following 1 minute of exposure to 0.12 % chlorhexidine digluconate, 50 % of 
fibroblastic cells and endothelial cells displayed apoptotic nuclei. Apoptotic indications are 
characterised by condensed nuclear chromatin, fragmented DNA, widespread cytoplasmic 
vacuolisation, and blebbing. However, necrotic cell death indications were present, such as an 
intact nucleus with dispersed chromatin, cytoplasmic vacuolisation, and the loss of plasma 
membrane integrity with the accompanying leakage of cytoplasmic content. Giannelli et al. 
(2008) investigated the effect of chlorhexidine digluconate on mitochondrial function using the 
membrane-permeant fluorochrome JC-1 dye. Furthermore, it was established that following 1 
minute of exposure to 0.01 % chlorhexidine digluconate, osteoblasts exhibited loss of 
mitochondrial transmembrane polarisation. In addition, the ability of chlorhexidine digluconate 
to disrupt the mitochondrial membrane potential was observed in both fibroblastic and 
endothelial cells. Giannelli et al. (2008) investigated the possible signalling pathways 
triggering chlorhexidine digluconate-induced cell death by analysing the capability of 
chlorhexidine digluconate to instigate intracellular calcium accumulation within osteoblasts. 
Furthermore, using the calcium indicator, Fluo-3 AM, it was established that the addition of 
0.01 % chlorhexidine digluconate triggered swift increases in both cytoplasmic and nuclear 
calcium ion concentration after 50 seconds. Additionally, using the oxidative stress indicator, 
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CM-H2 DCFDA, Giannelli et al. (2008) concluded that intracellular production of reactive 
oxygen species (ROS) commenced after 30 minutes of exposure to chlorhexidine digluconate. 
Furthermore, the cell lines used in the study conducted by Giannelli et al. (2008) were assumed 
to represent common targets for cytotoxic activity in the surgical procedures employed for the 
treatment of periodontitis and peri-implantitis. However, the results obtained provide 
constructive insight into chlorhexidine digluconates toxic effects on eukaryotic cells. Giannelli 
et al. (2008) concluded that chlorhexidine digluconate demonstrates elevated toxicity in 
different cell types in vitro and provided indication that intracellular signalling molecules 
contribute to the adverse effects of the compound. 
 
There are many cell-based assays that can be employed to determine whether test compounds 
exhibit effects on cell proliferation, or exhibit direct cytotoxic effects that will ultimately lead 
to cell death. Additionally, cell-based assays are commonly employed to measure receptor 
binding and a wide-range of signal transduction events that may include the expression of 
genetic reporters, trafficking of cellular components, or monitoring organelle function. 
Furthermore, tetrazolium reduction assays evaluate some aspects of general metabolism as 
markers of cell viability, and the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide tetrazolium) reduction assay represents the first homogenous cell viability assay 
developed for a 96-well plate format that was acceptable for high throughput screening (Riss 
et al., 2013). 
 
A conventional MTT assay includes preparing the MTT substrate in a physiologically balanced 
solution, administering the substrate to cells in culture media, and incubating the cells for 1-4 
hours. Following incubation, the insoluble formazan precipitate gathers inside the cell near the 
cell surface and within the culture medium. Prior to recording absorbance, solubilisation of the 
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formazan product is required in order to stabilise the colour; this can be achieved using 
acidified isopropanol or dimethyl sulfoxide (DMSO). The quantity of formazan generated is 
presumed to be directly proportional to the number of viable cells and is quantified by 
measuring shifts in absorbance at 570 nanometres (nm). Furthermore, the ability to convert 
MTT into formazan is not retained by dead cells (Riss et al., 2013). The conversion of MTT to 
formazan is facilitated by dehydrogenases located in the mitochondria of living cells, however 
enzymes and reducing agents occurring in other organelles, such as the endoplasmic reticulum, 
are also involved (van Tonder, Joubert & Cromarty, 2015). Parameters such as the 
concentration of MTT, the length of incubation, the number of viable cells, and their metabolic 
activity contribute to the amount of signal generated. In addition, certain culture conditions can 
adjust the metabolism of cells which will consequently affect the rate of MTT reduction to 
formazan. For example, the amount of MTT reduction per cell will decrease when the growth 
of adherent cells in a culture becomes contact inhibited, thus impeding metabolism. Therefore, 
the aforementioned circumstance will generate a loss of linearity between absorbance and cell 
number. Besides heightened confluence, other unfavourable culture conditions, such as altered 
pH or exhaustion of vital nutrients, such as glucose, may affect the ability of cells to reduce 
MTT (Riss et al., 2013). 
 
 
 
 
 
 
 
 
 
 
Figure 7. The conversion of MTT to the coloured formazan product by metabolically active 
cells. 
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Experimental 
 
 
Background Information for Experimental Procedures 
 
All practical research was conducted at the University of Salford. Laboratory consumables, 
chemicals, reagents, and media required for all aspects of the research were obtained from 
various scientific equipment suppliers. These suppliers included Sigma-Aldrich and Thermo 
Fisher Scientific. Furthermore, Crystal Clear International Limited financed the procurement 
of the necessary research materials. Crystal Clear International Limited provided the 
components used in their skin concentrate formula. Bacterial strains and mammalian cell lines 
were obtained from the University of Salford. Escherichia Coli, Staphylococcus Aureus, and 
Pseudomonas Aeruginosa were selected to be used in the antimicrobial susceptibility assays. 
Initially, all three species were maintained in brain heart infusion (BHI) broth and stored at 
4C. As the practical research progressed, all three species were eventually streaked onto 
separate Mueller-Hinton agar plates in order to obtain distinct single colonies. The agar plates 
were wrapped securely in parafilm and stored at 4C. Whenever it was necessary to obtain 
fresh cultures, single colonies were isolated from the appropriate agar plates and transferred 
into a suitable medium. All media associated with antimicrobial susceptibility testing was pre-
prepared in bulk, subjected to sterilisation in an autoclave, and safely stored in the relevant 
laboratory. HepG2 and A549 were the chosen adherent mammalian cell lines used in the 
cytotoxicity experiments. HepG2 is a cancerous liver-derived immortalised cell line and A549 
is a cancerous lung-derived immortalised cell line. Mammalian cell lines were stored in an 
appropriate cell culture incubator which provided appropriate conditions for the promotion of 
cellular growth and maintenance. In addition, mammalian cell lines were maintained in T75 
cell culture flasks. Maintaining cell lines involved employing the common practices associated 
with tissue cell culture. Furthermore, routine passaging was required to preserve cellular life, 
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as overly confluent cultures contain elevated quantities of toxic metabolites and decreased 
levels of nutrients. Initially, HepG2 was the chosen adherent cell line to be used in the 
cytotoxicity assays, however an early contamination setback required the need for a different 
cell line, A549, to be cultivated. Tissue cell culture reagents were stored in the appropriate 
manner. For long term use, complete media was stored at 4C, trypsin-EDTA was stored at -
20C, Penicillin-Streptomycin (10,000 U/mL) was stored at -20C, heat-inactivated fetal 
bovine serum (FBS) was stored at -20C, L-glutamine (2 mM) was stored at -20C, and 
phosphate-buffered saline (PBS) (1x) at pH 7.2 was stored at 4C. The chosen media was 
RPMI-1640. For long term use, MTT dye (3 mg/ml in PBS) was stored at -20C. Furthermore, 
all tissue cell culture reagents were handled in a sterile cabinet, and under no circumstances 
handled outside a sterile environment. Whenever practical research regarding tissue cell culture 
was performed, it was of the utmost importance to adhere relentlessly to aseptic criteria. On 
every occasion, the cell culture hood was allowed to establish a sterile environment for three 
minutes before any work was conducted. Once a sterile environment had been established, the 
work surface within the hood was thoroughly sanitised with 1 % virkon, followed by 70 % 
ethanol. All equipment that was placed in the cell culture hood was sprayed thoroughly with 
70 % ethanol. Before conducting work in the cell culture hood, gloves were habitually sanitised 
with 70 % ethanol. 
 
For the antimicrobial susceptibility assays that required 96-well plates, the number used for 
each occasion varied. Furthermore, as this was a yearlong practical research project, the 
experimental design varied with regards to the number of repeats of treated cells. In addition, 
the number of repeats concerning both positive and negative controls varied throughout the 
research. On every occasion the MTT assay was performed, one 96-well plate was used to 
minimise the risk of contamination. However, similar to the antimicrobial susceptibility assays, 
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the experimental design was subjected to slight alterations with regards to the number of 
repeats of treated cells. In addition, the number of repeats concerning both positive and 
negative controls varied throughout the research. 
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Preparation of Crystal Clear Skin Concentrate 
 
The preparation of the skin concentrate was conducted using a batch manufacturing sheet 
provided by Crystal Clear. The sheet detailed the procedure used by Crystal Clear to produce 
the skin concentrate, including the ingredients and the quantities required. The procedure 
followed by Crystal Clear was intended for the production of huge quantities of skin 
concentrate; a single batch is required to be made up to 1000 litres. Furthermore, it would be 
unfeasible to replicate the procedure entirely in a university laboratory. Such an approach 
would require large amounts of resources and demand large amounts of laboratory space for 
the procedure to be performed. Therefore, an alternative method had to be designed which 
would be far more economical with regards to laboratory space and resources. To combat this 
issue, the quantities of each ingredient were reduced, however the appropriate ratio of 
ingredients within the formula was maintained. The following method represents an adapted 
version of the procedure employed by Crystal Clear to manufacture the skin concentrate. 
 
To produce skin concentrate (500 mL) as dictated by Crystal Clear, H2O (382.5 mL) was added 
to a suitably sized beaker.  EDTA (7.5 g) was subsequently added and the contents of the beaker 
was continually stirred for a duration of 10 minutes. Didecyldimethylammonium chloride 
(BTC101E) (38.4 mL), benzyl-C12-14-alkyldimethylammonium chlorides (BAC50) (41.6 
mL), and chlorhexidine digluconate (30 mL) (20 %) (aq) were added to the beaker in turn; 
followed by constant stirring for a duration of 10 minutes. The pH of the solution was adjusted 
to be within a range of 6.5-7.5 using citric acid solution. 
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Preparation of Silver Ions in Solution 
 
The preparation of silver ions in solution was performed using a rudimentary method. To 
generate silver ions, a Dowex G26 hydrogen form cation exchange resin was used. The cation 
exchange resin was washed with ethanol (3 x 25 mL). The exchange resin was dried using a 
water aspirator to generate a vacuum. The dried cation exchange resin was stirred continuously 
for 2 hours with AgNO3 (aq). Vacuum filtration was used to separate the solution from the cation 
exchange resin. The resin was subsequently dried in a laboratory oven. The resin was stirred 
continuously for 2 hours with deionised H2O. Vacuum filtration was used to separate the 
solution of silver ions from the cation exchange resin. To confirm the presence of silver ions 
in solution, both visual and quantitative methods were employed. To quantitatively measure 
the concentration of silver ions in solution, inductively coupled plasma mass spectrometry 
(ICP-MS) was used. Visual confirmation was performed using a dilute solution of HCL (aq) (0.5 
M) in order to generate the white insoluble precipitate of AgCl (s). 
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Gram Stain 
 
The presence of a net negative charge on the surface of bacteria allows cationic dyes, such as 
crystal violet dye, to adhere to them. The Gram stain is used to differentiate bacteria into Gram-
positive or Gram-negative. Differentiation is based on cell wall composition, with Gram-
positive bacteria possessing a thick peptidoglycan-containing cell wall. In order to prepare the 
bacterial sample, a fresh single colony from an overnight agar plate was suspended in sterile 
distilled water. Using a sterile pipette dropper, a drop was placed on a clean slide and cautiously 
heat fixed using a Bunsen burner. Once the bacterial sample had been successfully heat fixed 
to the slide, ‘ammonium-oxalate-crystal violet’ was applied to the slide; ensuring that the entire 
bacterial film was covered. The dye was left to act for 30 seconds. The dye readily penetrates 
the cells of Gram-positive bacteria, and the outer membrane of Gram-negative bacteria, by 
means of associating with the negative elements of the cell. After 30 seconds, the excess dye 
was carefully removed using water. After the first washing step, Grams iodine was applied; 
ensuring that the entire bacterial film was covered. Grams iodine was left to act for 30 seconds. 
Grams iodine associates with crystal violet dye generating a crystal violet-iodine complex. 
After 30 seconds, the reagent was discarded appropriately, however the slide was not subjected 
to a thorough washing step. After the excess reagent had been carefully discarded, the entire 
slide was exposed to ethanol for 15 seconds. The purpose of this step was to remove the crystal 
violet-iodine complexes from Gram-negative bacteria; this is achieved by removing the outer 
membrane and leaving the cell wall exposed. The much structurally thinner cell wall of Gram-
negative bacteria releases the crystal violet-iodine complexes, whereas the structurally thicker 
cell wall of Gram-positive bacteria retains the dye. Following treatment with ethanol, the entire 
slide is swiftly and thoroughly washed with water. Following the washing step, the whole slide 
was covered with safranin. Following the application of the counterstain, the entire slide was 
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washed with water to remove any excess dye and allowed to air dry. Once the slide was 
sufficiently dried, the stained bacterial film could be visualised under a microscope. 
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Disk Diffusion Assay 
 
The disk diffusion assay was primarily employed to confirm if a particular compound or 
formulation possessed antimicrobial capabilities. In the disk diffusion assay, antimicrobial 
capabilities were confirmed by means of visual indications. For every occasion the disk 
diffusion assay was performed, preparation of antimicrobial compounds and the subsequent 
assay were performed aseptically, thus requiring the use of a Bunsen burner to establish an 
aseptic zone. In addition to establishing an aseptic zone, each antimicrobial compound was 
sterile filtered, using a 0.22 m filter, before use in the assay. Sterile distilled water was used 
as the diluent if dilutions were required. Commodities associated with dispensing liquids, such 
as pipette tips, were sterilised before use in the assay in order to reduce the risk of erroneous 
results due to contamination. 
 
Following the preparation of test compounds, 20 L of each was applied to a disk and stored 
at room temperature for a duration of 1 hour. Following disk permeation, bacterial suspensions 
were prepared by directly removing single colonies from stored plates and adjusting the 
turbidity to correspond to that of McFarland 1 in sterile distilled water. Using sterile cotton 
swabs, Mueller-Hinton agar plates were inoculated with adjusted bacterial suspensions. The 
disks were transferred to the agar plates with a maximum of three disks per plate and placed in 
an incubator, set at 37C, overnight. Antimicrobial capabilities were evaluated by measuring 
the zone of inhibition around the disk in millimetres (mm). 
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Optical Density Assay 
 
Although not recognised as an official antimicrobial susceptibility assay, the optical density 
assay was performed in order to assess the progression of a compounds antimicrobial activity 
in a real-time setting. Before attempting the assay, it was necessary to select the appropriate 
media. The rationale behind selecting appropriate media was the tendency of various 
compounds to chemically react with various types of media. Furthermore, these reactions 
produced precipitates which would generate erroneous data. For the purpose of selecting 
appropriate media through trial and error, aseptic techniques were not required as live 
organisms were not being handled in these experiments. In order for the trial and error 
experiments to be conducted in an economical sense, the experiments were performed in 96-
well plates. By applying 100 L of test compound, at a relevant concentration, to 100 L of 
different types of media in a 96-well plate, it was possible to identify a suitable type of media 
for the optical density assay. Lysogeny broth (LB) was found to be a suitable liquid medium 
for the optical density assay as it did not react readily with chlorhexidine digluconate or diluted 
skin concentrate. Furthermore, if a precipitation reaction was to occur, it would occur at a 
higher concentration of chlorhexidine digluconate, however the intensity of the precipitate 
would not be substantial enough to interfere with the optical density assay. In contrast, brain 
heart infusion (BHI) broth was prone to instantly react with chlorhexidine digluconate, thus it 
was appropriately disregarded as the liquid growth medium in the optical density assay. 
 
The optical density assay procedure largely resembled the procedure described by Ashraf et al. 
(2012) and the aforementioned procedure included the use of LB media. Aseptic techniques 
were rigorously employed throughout the course of the assay. All inoculations were performed 
in a sterile environment by using a Bunsen burner to provide an aseptic atmosphere and 
sterilised loops were used. In addition, monitoring absorbance values at regular intervals was 
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achieved using sterile disposable pipette droppers and adhering to aseptic standards. 
Additionally, the appropriate blanks were used to calibrate the spectrophotometer before being 
used to monitor absorbance values. Moreover, the blanks were prepared aseptically in order to 
eliminate contamination risks if the assay was to be conducted during the course of a day. 
Commodities associated with dispensing liquids, such as pipette tips, were sterilised before use 
in the assay to reduce the risk of erroneous results due to contamination. Flasks containing LB 
media were composed before the assay and subjected to sterilisation. Furthermore, all 
antimicrobial compounds were subjected to sterile filtration, using a 0.22 m filter, before use 
in the assay. 
 
Bacterial strains were prepared by transferring a loopful of stored bacterial suspension into 10 
mL of fresh LB media and placed in a shaking incubator, at 37C, set at 200 revolutions per 
minute (rpm). Following overnight incubation, 100 L of bacterial suspension was transferred 
into 10 mL of fresh LB media and subjected to further agitated incubation at 37C. When the 
absorbance of all bacterial suspensions reached 1 at 600 nanometres (nm), all cultures were 
diluted by transferring 1 mL of culture into flasks containing 99 mL of fresh LB media, thus 
obtaining dilutions at 1:100. For each strain tested, there were three flasks; a positive control, 
a negative control, and a test flask. The positive control flask contained a standardised bacterial 
suspension. The negative control flask contained purely LB media. The test flask contained a 
standardised bacterial suspension and a test compound. Once 1 mL of test compound was added 
to the test flask, the absorbance of each flask was recorded at 600 nm, and all flasks were placed 
in a shaking incubator set at 200 rpm with an internal temperature of 37C. At regular intervals, 
the contents of each flask was monitored by recording optical density values at 600 nm. 
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Broth Dilution Assay 
 
The broth dilution assay was performed in order to establish minimum inhibitory concentration 
(MIC) values for antimicrobial compounds and formulations. Additionally, the broth dilution 
assay was performed in order to establish minimum bactericidal concentration (MBC) values. 
The assay was performed in accordance with the EUCAST guidelines where possible. For 
every occasion the broth dilution assay was performed, aseptic techniques were employed 
when preparing antimicrobial compounds and when performing the assay to alleviate 
contamination concerns. Aliquoting media was performed in a sterile cabinet using disposable 
sterile pipettes. All stock antimicrobial test compounds were sterile filtered, using a 0.22 m 
filter, in a sterile cabinet before the subsequent dilutions were composed using sterile distilled 
water as the diluent. The two-fold serial dilution technique was the preferred technique 
employed for the preparation of test compound dilutions. On occasion, the ten-fold serial 
dilution technique was employed. Inoculations were performed using a Bunsen burner to 
provide an aseptic atmosphere and standardised bacterial suspensions were plated in a sterile 
cabinet. Monitoring absorbance values was performed aseptically using sterile pipette droppers 
in order to dispense aliquots of bacterial suspensions into disposable cuvettes. The treatment 
of bacterial cell suspensions with test compounds was performed in a sterile cabinet. The 
attainment of the MBC was performed aseptically, either by a flame or in a sterile cabinet. 
Furthermore, on every occasion the broth dilution assay was performed, it was necessary to 
ensure that all equipment associated with dispensing liquids, such as pipette tips, was sterilised 
before use. 
 
The preparation of bacterial suspensions involved isolating a single colony from each stored 
strain of bacteria and transferring each colony into separate universal tubes containing 10 mL 
of sterile Mueller-Hinton broth. The tubes were placed in a shaking incubator, set at 200 
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revolutions per minute (rpm), for overnight incubation at 37C. Following incubation, each 
fresh culture was sub-cultured by transferring 200 L of each suspension into separate 
universal tubes containing 10 mL of Mueller-Hinton broth and subjected to further agitated 
incubation at 37C. At regular intervals, the absorbance of each suspension was monitored at 
600 nanometres (nm) until 0.5 was achieved for all strains. Once an absorbance of 0.5, or 
thereabouts, had been achieved for each suspension, all suspensions were diluted in fresh 
double-strength Mueller-Hinton broth to achieve an absorbance of 0.01-0.05 at 600 nm. 
 
Once all bacterial suspensions had been standardised, 100 L were dispensed into the 
individual wells of 96-well plates. Appropriate wells were omitted for the purpose of 
establishing negative controls by dispensing 100 L of purely sterile broth into them. 100 L 
of test compound was dispensed into the appropriate wells containing a standardised bacterial 
suspension, and wells were left untreated for the purpose of establishing positive controls. Once 
the appropriate wells had been treated, the 96-well plates were placed in an incubator, set at 
37C, overnight. To allow more dilutions to be evaluated, test compounds were applied to the 
96-well plates in a horizontal fashion. In general, three repeats were adequate for each dilution 
for a given strain of bacteria. In addition, the number of repeats for both sets of controls was 
endeavoured to be two. 
 
Following overnight incubation, the wells were visually inspected in order to determine the 
MIC. The MIC was ascertained by highlighting the last well exhibiting no bacterial growth. 
Furthermore, the corresponding concentration was designated as the MIC value. Once the MIC 
was ascertained visually, all plates were placed in a microtiter-plate reader and absorbance 
values were recorded at 600 nm. In some cases, a visual aid was required such as resazurin dye 
in order to assist in determining the MIC. On every occasion resazurin was required, it was 
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composed on the day it was required and then appropriately discarded. 0.2  resazurin dye was 
composed by combining one resazurin tablet with 12.5 mL of sterile distilled water and 
homogenising the mixture using a vortex mixer. Resazurin dye was sterile filtered before being 
applied to the 96-well plates. Each well of a 96-well plate was treated with 30 L of 0.2 % 
resazurin dye. All plates that had been treated with resazurin dye were subjected to 1 hour of 
incubation, at 37C, to allow the reduction of resazurin in the presence of viable cells to occur. 
Furthermore, viable cells with their metabolic activity intact will convert resazurin to resorufin, 
which exhibits a fluorescent, pink colour. 
 
On occasion, it was necessary to obtain the minimum bactericidal concentration (MBC). The 
MBC was obtained by sub-culturing from three wells upstream from the MIC. Sub-culturing 
was achieved by extracting 100 L from the appropriate wells and preparing a ten-fold dilution 
series of each in Mueller-Hinton broth. From the ten-fold dilution series, 20 L was dispensed 
onto Mueller-Hinton agar plates and evenly spread using a sterile spreader. The plates were 
incubated overnight at 37C. The number of viable cells, colony-forming units per millilitre 
(CFU/mL), was calculated by selecting all agar plates that contained between 30 and 300 
distinct colonies. The MBC was determined as the minimum concentration corresponding to a 
99.9 % reduction in viable cells. 
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Crystal Violet Assay for Biofilm Quantification 
 
The crystal violet assay was performed in order to assess biofilm production by certain bacterial 
strains. Biofilms represent a significant obstacle in the medical environment and research 
associated with combating their elevated resistance to disinfectants has received substantial 
attention. However, it must be firmly established that the purpose of the following assay was 
to quantify biofilm production by selected bacterial strains when exposed to certain 
experimental conditions outlined by Bonaventura et al. (2007). The assay described by 
Bonaventura et al. (2007) was later modified to include treatment of selected bacterial strains 
with test compound. However, this modification was very rudimentary and limited with regards 
to the conclusions that could be drawn from it. Furthermore, the modified assay was able to 
assess a test compounds ability to inhibit biofilm production, however it was not suitable for 
assessing a test compounds ability to eradicate pre-existing biofilms. 
 
The following assay was performed using the required aseptic practices to minimise the risk of 
contamination. All inoculations were performed in an aseptic area provided by a Bunsen burner 
and a sterile cabinet was used for the purpose of plating bacterial strains. On every occasion 
the assay was performed, pipette tips and media were subjected to sterilisation in an autoclave. 
Aliquoting media was performed in a sterile cabinet using sterile disposable pipettes. For this 
particular assay, tryptic soy broth (TSB), supplemented with 1 % glucose, was required. Using 
distilled water as the diluent, 1 % crystal violet dye was obtained from crystal violet powder 
and subsequently filtered through a bottle-top sterile filter unit. 
 
To prepare the inoculum, a single colony of each bacterial strain was removed from each stored 
strain of bacteria and transferred into supplemented TSB for incubation overnight at 37C. 
Following overnight incubation, each culture was diluted in fresh supplemented TSB media to 
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achieve a 1:100 dilution by transferring 200 L of culture into 19.8 mL of fresh TSB. 200 L 
of diluted culture was deposited into the appropriate wells of a flat bottomed 96-well plate. For 
purely biofilm quantification, the general plate layout consisted of three repeats for each strain 
and two repeats of negative controls. Negative controls contained purely sterile media. When 
test compounds were applied, the plate layout consisted of three repeats for each strain tested, 
two repeats of negative controls, and two repeats of positive controls. Furthermore, the volume 
of test compound added to the appropriate wells was equivalent to the volume of bacterial 
suspension. However, it must be established that the pre-determined plate layout was not 
adhered to on occasion. Inoculated plates were incubated, at 37C, for a duration of 48 hours 
without agitation. Following incubation, the absorbance of each well was recorded at a 
wavelength of 570 nanometres (nm) in a microtiter-plate reader. Once the absorbance values 
had been obtained, the entire contents of each well were carefully aspirated. The removal of 
planktonic cells and media received careful consideration due to the high possibility of 
damaging the biofilm integrity. Furthermore, the following steps in the assay did not require 
an aseptic environment. Once the contents of each well was carefully removed and 
appropriately discarded, plates were washed in order to guarantee complete removal of all non-
adherent cells whilst preserving the biofilm integrity. Washing plates involved gently 
submerging them in a container of distilled water and carefully emptying the wells by flicking 
the plates. Alternatively, the wells could be emptied by gentle aspiration with a pipette to 
minimise damage to the biofilm layer. However, the latter procedure was exceedingly time-
consuming. Individual plates were washed three times in order to ensure complete removal of 
non-adherent cells. After all wells had been sufficiently washed, all plates were left overnight 
at room temperature in an inverted position to dry. 200 L of 1 % crystal violet solution was 
added to each well and all plates were left at room temperature for a duration of 50 minutes to 
allow the crystal violet dye to penetrate the biofilm layer. Following a suitable exposure time, 
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excess crystal violet dye was removed and all wells were subjected to gentle washing as 
described previously to remove unbound dye. Following the washing procedure, all plates were 
left to air dry at room temperature for 3 hours. Resolubilisation of the dye was achieved by 
dispensing 150 L of 99.8 % methanol into each well. Furthermore, the process of liberating 
crystal violet dye from adherent cells using methanol enabled indirect but precise measurement 
of biofilm production. The optical density was recorded for all plates at 570 nm in a microtiter-
plate reader. 
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Tissue Cell Culture 
 
Before an MTT assay could be attempted, mammalian cells were grown and maintained in 
meticulous fashion in order to avoid bacterial contamination. Mammalian cells were habitually 
monitored and passaged in order to maintain a healthy cell line. All tissue cell culture work 
was performed in a sterile cabinet. All reagents required for the composition of complete media 
were pre-warmed at 37C for 15 minutes. To compose 100 mL of complete media 
supplemented with 10 % fetal bovine serum (FBS) and 1 % L-glutamine necessary for the 
cultivation of mammalian cells, 89 mL of media was dispensed into a sterile flask. 1 mL of L-
glutamine and 10 mL of FBS were subsequently added to the flask. 
 
On occasion it was necessary to resuscitate a frozen cell line for cytotoxicity studies. Cell 
culture stocks are frozen at -80C and protected from freezing damage by 10 % (v/v) dimethyl 
sulfoxide (DMSO). Complete media was pre-warmed at 37C for 15 minutes before being 
used. To resuscitate a cell line, the cap of the cryogenic vial was carefully loosened to liberate 
any residual liquid nitrogen. With extreme caution and haste, the cryogenic vial was thawed in 
a water bath set at 37C until one or two crystals were visible. Aseptically, the contents of the 
vial were placed in a tube containing 8 mL of pre-warmed complete media and subjected to 
centrifugation at 2000 revolutions per minute (rpm) for 5 minutes. The supernatant was 
discarded and the pellet was thoroughly resuspended in 10 mL of complete media; ensuring 
thorough dissociation of cells. The cell suspension was subsequently added to 10 mL of 
complete media in an appropriate tissue flask. Following inoculation, the contents of the flask 
was gently swirled to ensure even distribution. The flask was placed in an appropriate tissue 
cell culture incubator set at 37C. 
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Sub-culturing is essential for the continuation of an adherent cell line. Before use, complete 
media, sterile phosphate-buffered saline (PBS) and sterile trypsin-EDTA were pre-warmed at 
37C for 15 minutes. From a pre-existing flask of confluent cells, the media was appropriately 
discarded and 10 mL of PBS was dispensed into the tissue flask. The flask was gently swirled 
for a duration of 2 minutes. Following gentle agitation, the PBS was extracted from the flask 
and discarded. 2 mL of trypsin-EDTA was dispensed into the flask and the flask was 
subsequently incubated for 5 minutes. To achieve a 1 in 6 passage, 7 mL of media was 
dispensed into the flask to inactivate the trypsin-EDTA. 1.5 mL of the cell suspension was 
added to a new flask containing 18.5 mL of complete media. The newly composed flask of 
cells was placed in a tissue cell incubator at 37C. 
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MTT Assay to Evaluate Cytotoxicity 
 
The assessment of cytotoxicity towards a mammalian cell line was achieved using the MTT 
(3-4(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide tetrazolium) reduction assay. 
Before application, antibacterial compounds were sterile filtered using a 0.22 m sterile filter. 
Dilutions of antibacterial compounds were performed using sterile distilled water as the diluent. 
Both the two-fold serial dilution method and the ten-fold serial dilution method were used. 
Pipette tips required for the extracting and dispensing of liquid were sterilised before use in the 
assay. Before use in the assay, complete media, sterile PBS, and sterile trypsin-EDTA were 
pre-warmed at 37C for 15 minutes. The preparation and application of MTT dye solution was 
performed in a tissue cell culture cabinet. 
 
Once the cells had reached the desired confluency, they were used in the MTT assay. The cell 
monolayer was washed and trypsinized in accordance with the aforementioned sub-culturing 
protocol. From the 9 mL of cell suspension, 0.5 mL was dispensed into an Eppendorf tube. 
From the 0.5 mL of cell suspension, a further 100 L was extracted and mixed thoroughly with 
0.4 % tryphan blue solution in a fresh Eppendorf tube. From the mixture, 20 L was dispensed 
into a haemocytometer in order to calculate the concentration of viable cells using an inverted 
microscope. Furthermore, cells that appeared stained were not viable and disregarded in the 
subsequent calculations to obtain the viable cell concentration. Once the concentration, per L, 
of viable cells was ascertained, the required concentration of cell solution for the assay was 
obtained. In general, each well of a flat-bottomed, 96-well plate was inoculated with 100 L 
of cell suspension with a concentration of 75 cell/L. Once all the appropriate wells had been 
inoculated, the 96-well plate was placed in an appropriate tissue cell culture incubator at 37C 
overnight to allow the cells to adhere to the base of the wells. 
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Once it was established that the plate was free from contamination and the cells had adhered 
successfully to the base of the well, the cells were treated with test compound. 100 L of test 
compound was added to each well containing cells. A number of wells were left free of test 
compound in order to serve as positive controls. Sterile complete media was dispensed into the 
remaining empty wells to serve as negative controls. In general, 2-4 repeats of treated cells per 
test compound were plated, two repeats of positive controls were plated, and two repeats of 
negative controls were plated. Once the cells had been treated with the relevant test compound, 
the 96-well plate was incubated overnight at 37C. 
 
Following overnight incubation, the wells were treated with MTT dye solution. In order to 
compose MTT dye solution (3 mg/mL in PBS), 0.06 grams of MTT powder was dissolved in 
20 mL of PBS using a vortex mixer to ensure the solution was thoroughly homogenised. As 
MTT dye solution is photosensitive, the solution was wrapped in aluminium foil to protect it 
from light exposure. 30 L of MTT dye solution was added to all wells and the plate was 
incubated at 37C for 3 hours; this was to allow MTT to be converted to formazan during this 
time period. Furthermore, the formazan crystal appears purple when generated by viable cells. 
Following incubation, the contents of each well were carefully aspirated using a vacuum; 
ensuring not to disturb the formazan product. Once the contents from each well had been 
carefully extracted, 100 L of dimethyl sulfoxide (DMSO) was added to all wells to solubilise 
the formazan crystal. The absorbance of each well was recorded at 540 nanometres (nm) and 
690 nm using a microtiter plate reader. 
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Results 
 
 
Optical Density Assay 
 
The antimicrobial effect of the disinfectant skin concentrate, diluted to 6 % (v/v) as dictated by 
Crystal Clear, was evaluated against S. aureus using the optical density assay. Absorbance 
values at 600 nanometres (nm) were used to measure bacterial density. In addition, a positive 
control was included which exclusively contained S. aureus. The positive control essentially 
represents the growth of S. aureus over a 7-hour time period. Furthermore, all absorbance 
values recorded at 2.5 cannot be considered entirely accurate as the spectrophotometer used did 
not record readings surpassing 2.5. 
Figure 8. A graph to show the effect of a diluted skin concentrate formula at 6% (v/v) on the 
growth of S. aureus over a 7-hour time period. 
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Broth Dilution Assay 
 
Standardised cultures of S. aureus, E. coli and P. aeruginosa were subjected to two-fold serial 
dilutions of chlorhexidine digluconate in order to determine the minimum inhibitory 
concentration (MIC). Absorbance values at 600 nanometres (nm) were used to measure 
bacterial density. To visually confirm the presence of a viable culture or not, or to alleviate 
concerns regarding contamination, the resazurin reduction assay was employed. The starting 
concentration of chlorhexidine digluconate was 2 % (v/v). 
 
Table 1. A table to show the effects of two-fold serially diluted concentrations of chlorhexidine 
digluconate on three different strains of bacteria by recording absorbance values at 600 
nanometres (nm). All values represented in this table are averages. CHX = chlorhexidine 
digluconate. 
Sample Dilution 
S. 
aureus 
& CHX 
(n=2)  
Positive 
Control 
S. 
aureus 
(n=1) 
E. coli & 
CHX 
(n=2) 
Positive 
Control 
E. coli 
(n=1) 
P. 
aeruginosa 
& CHX 
(n=2) 
Positive 
Control P. 
aeruginosa 
(n=1) 
Negative 
Control 
(n=2) 
 1 2.128 1.679 2.25 1.767 2.421 2.326 0.164 
 2-1 2.384 1.17 2.367 1.856 2.458 2.086 0.117 
 
Absorbance 
2-2 2.814 1.073 2.764 1.827 2.366 2.533 0.155 
(arbitrary 
units) 
2-3 2.293 1.319 1.579 1.746 1.471 1.518 0.157 
 2-4 1.246 1.322 0.672 1.735 0.624 1.413 0.136 
 2-5 0.462 1.22 0.305 1.778 0.291 1.223 0.116 
 2-6 0.162 1.231 0.076 1.746 0.075 1.244 0.149 
 2-7 0.053 1.43 0.052 1.809 0.046 1.344 0.098 
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The assay was repeated using the same experimental design, however all three strains were 
subjected to ten-fold serial dilutions of chlorhexidine digluconate to further distinguish the 
effects between high and low concentrations of chlorhexidine digluconate on standardised 
bacterial cultures. The starting concentration of chlorhexidine digluconate was 2 % (v/v). 
 
Table 2. A table to show the effects of ten-fold serially diluted concentrations of chlorhexidine 
digluconate on three different strains of bacteria by recording absorbance values at 600 
nanometres (nm). All values represented in this table are averages. CHX = chlorhexidine 
digluconate. 
Sample Dilution 
S. 
aureus 
& CHX 
(n=2)  
Positive 
Control 
S. 
aureus 
(n=1) 
E. coli 
& 
CHX 
(n=2) 
Positive 
Control 
E. coli 
(n=1) 
P. 
aeruginosa 
& CHX 
(n=2) 
Positive 
Control  
P. 
aeruginosa 
(n=1)  
Negative 
Control 
(n=3) 
 1 1.98 0.406 2.175 1.09 2.627 0.085 0.031 
(0.002) 
 10
-1 1.238 1.655 1.032 2.762 1.326 0.888 0.038 
(0.006) 
 
Absorbance 
10-2 0.047 1.372 0.042 1.953 0.042 1.55 0.035 
(0.004) 
(arbitrary 
units) 
10-3 0.04 1.12 0.126 2.062 0.038 1.235 0.036 
(0.003) 
 10-4 1.083 1.06 1.771 2.322 1.151 1.348 0.038 
(0.002) 
 10-5 0.481 1.04 1.822 2.227 1.333 1.661 0.038 
(0.002) 
 10-6 0.572 1.2 1.749 1.803 1.341 0.704 0.035 
(0.003) 
 10-7 0.604 1.585 1.486 1.867 1.516 0.095 0.036 
(0.006) 
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The antimicrobial effects of the disinfectant skin concentrate and chlorhexidine digluconate 
were evaluated against a standardised inoculum of Gram-negative E. coli. Both agents were 
ten-fold serially diluted. In addition, a column of the 96-well plate was used to evaluate the 
intensity of background signal interference generated by the reaction between chlorhexidine 
digluconate and Mueller-Hinton microbiological growth medium. The starting concentration 
of chlorhexidine digluconate was 1 % (v/v). 
 
Table 3. A table to show the effects of ten-fold serially diluted concentrations of chlorhexidine 
digluconate and skin concentrate on E. coli by recording absorbance values at 600 nanometres 
(nm). All values represented in this table are averages. CHX = chlorhexidine digluconate. SC 
= skin concentrate. 
Sample Dilution 
E. coli & 
CHX (n=3) 
E. coli & SC 
(n=3) 
Positive 
Control (n=2) 
Negative 
Control (n=2)  
CHX & 
Mueller-
Hinton broth 
(n=1) 
 1 0.823 
(0.6) 
0.196 
(0.03) 
0.165 0.052 1.236 
 10-1 1.514 
(0.7) 
0.401 
(0.05) 
0.573 0.153 0.543 
 
Absorbance 
10-2 0.054 
(0.009) 
0.058 
(0.006) 
1.711 0.176 0.045 
(arbitrary 
units) 
10-3 0.052 
(0.004) 
0.045 
(0.002) 
1.846 0.104 0.045 
 10-4 1.356 
(0.05) 
1.444 
(0.09) 
1.698 0.083 0.049 
 10-5 1.413 
(0.05) 
1.366 
(0.05) 
1.705 0.067 0.046 
 10-6 1.307 
(0.03) 
1.267 
(0.02) 
1.715 0.077 0.045 
 10-7 1.233 
(0.07) 
1.214 
(0.02) 
1.828 0.067 0.044 
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The antimicrobial effects of the disinfectant skin concentrate and chlorhexidine digluconate 
were evaluated against a standardised inoculum of Gram-positive S. aureus. Both agents were 
ten-fold serially diluted. In addition, two columns of the 96-well plate were used to evaluate 
the intensity of background signal interference generated by chlorhexidine digluconate and 
skin concentrate reacting with Mueller-Hinton microbiological growth medium. 
 
Table 4. A table to show the effects of ten-fold serially diluted concentrations of chlorhexidine 
digluconate and skin concentrate on S. aureus by recording absorbance values at 600 
nanometres (nm). All values represented in this table are averages. CHX = chlorhexidine 
digluconate. SC = skin concentrate. 
Sample Dilution 
S. aureus 
& CHX 
(n=3) 
S. aureus 
& SC 
(n=3) 
Positive 
Control 
(n=2) 
Negative 
Control 
(n=2) 
CHX & 
Mueller-
Hinton 
broth (n=1) 
SC & 
Mueller-
Hinton 
broth (n=1) 
 1 2.056 
(0.6) 
0.761 
(0.2) 
0.491 0.042 2.363 0.858 
 10-1 0.681 
(0.06) 
0.253 
(0.04) 
1.355 0.187 0.56 0.143 
 
Absorbance 
10-2 0.041 
(0.008) 
0.049 
(0.003) 
0.956 0.102 0.041 0.043 
(arbitrary 
units) 
10-3 0.040 
(0.002) 
0.039 
(0.001) 
0.982 0.084 0.05 0.05 
 10-4 0.477 
(0.1) 
0.552 
(0.1) 
0.988 0.061 0.04 0.048 
 10-5 0.523 
(0.1) 
0.451 
(0.09) 
1.056 0.041 0.045 0.045 
 10-6 0.564 
(0.1) 
0.482 
(0.1) 
1.168 0.043 0.04 0.045 
 10-7 0.757 
(0.04) 
0.677 
(0.1) 
1.286 0.106 0.053 0.041 
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To eliminate background signal interference, two-fold serial dilutions of chlorhexidine 
digluconate, from a starting concentration of 0.01 % (v/v), were evaluated against S. aureus 
and E. coli. 
 
Table 5. A table to show the effects of two-fold serially diluted concentrations of chlorhexidine 
digluconate on S. aureus and E. coli by recording absorbance values at 600 nanometres (nm). 
All values represented in this table are averages. CHX = chlorhexidine digluconate. 
Sample Dilution 
S. aureus & 
CHX (n=2) 
E. coli & 
CHX (n=2) 
Positive 
Control E. 
coli (n=1) 
Positive 
Control S. 
aureus  (n=1) 
Negative 
Control 
(n=2) 
 1 0.038 0.041 1.717 1.465 0.203 
 2-1 0.030 0.036 1.599 1.022 0.156 
 
Absorbance 
2-2 0.035 0.04 1.499 0.93 0.121 
(arbitrary units) 2-3 0.032 0.039 1.683 0.893 0.125 
 2-4 0.03 0.039 1.505 0.895 0.121 
 2-5 0.031 0.039 1.516 0.846 0.139 
 2-6 0.545 1.32 1.644 0.95 0.14 
 2-7 0.729 1.506 1.422 0.976 0.155 
 2-8 0.655 1.471 1.495 1.083 0.184 
 2-9 0.761 1.546 1.492 1.079 0.196 
 2-10 0.683 1.54 1.508 0.963 0.171 
 2-11 1.359 1.804 1.757 1.482 0.094 
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Biofilm Assay 
 
The ability of two-fold serial dilutions of chlorhexidine digluconate and hydrogen peroxide to 
inhibit the development of biofilm generated by a standardised inoculum of S. aureus was 
evaluated. Absorbance values at 570 nanometres (nm) were recorded. In addition, two columns 
of the 96-well plate were used to evaluate the intensity of background signal interference 
generated by chlorhexidine digluconate and skin concentrate reacting with tryptone soya 
microbiological growth medium. The starting concentration of chlorhexidine digluconate was 
1 % (v/v) and the starting concentration of hydrogen peroxide was 3 % (v/v). 
 
Table 6.  A table to show the effects of two-fold serially diluted concentrations of chlorhexidine 
digluconate and hydrogen peroxide on the development of biofilm produced by S. aureus 
following the application and solubilisation of crystal violet dye. Absorbance values were 
recorded at 570 nanometres (nm). All values represented in this table are averages. CHX = 
chlorhexidine digluconate. 
Sample Dilution 
S. aureus & 
CHX (n=2) 
S. aureus & 
Hydrogen 
Peroxide 
(n=2) 
Positive 
Control 
(n=2) 
Negative 
Control (n=2) 
CHX & 
Tryptone 
Soya broth 
(n=1) 
 1 3.5 0.212 0.268 0.263 3.5 
 2-1 3.5 0.204 0.31 0.201 3.5 
 
Absorbance 
2-2 3.461 0.212 0.383 0.207 3.34 
(arbitrary 
units) 
2-3 2.892 0.206 0.458 0.197 3.03 
 2-4 2.709 0.218 0.428 0.194 2.4 
 2-5 2.673 0.201 0.315 0.228 3.373 
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The ability of two-fold serial dilutions of two broad spectrum antimicrobial compounds, acetic 
acid and hydrogen peroxide, on the inhibition of biofilms generated by P. aeruginosa was 
evaluated. The starting concentration of acetic acid was 0.25 % (v/v). 
 
Table 7. A table to show the effects of two-fold serially diluted concentrations of acetic acid 
and hydrogen peroxide on the development of biofilm produced by P. aeruginosa following 
the application and solubilisation of crystal violet dye. Absorbance values were recorded at 570 
nanometres (nm). 
Sample Dilution 
P. aeruginosa & 
Hydrogen 
Peroxide (n=1) 
P. aeruginosa & 
Acetic Acid 
(n=1) 
Positive  
Contr4ol (n=1) 
Negative 
Control (n=1) 
 1 0.18 0.172 0.5 0.17 
 2-1 0.195 0.663 0.816 0.183 
 
Absorbance 
2-2 0.156 0.853 0.924 0.178 
(arbitrary units) 2-3 0.154 0.799 0.96 0.182 
 2-4 0.155 0.891 0.96 0.203 
 2-5 0.452 0.787 0.834 0.169 
 2-6 0.597 0.789 0.823 0.173 
 2-7 0.608 0.716 0.427 0.178 
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The ability of two-fold serial dilutions of acetic acid and chlorhexidine digluconate to inhibit 
the development of biofilm generated by P. aeruginosa was evaluated. 
 
Table 8. A table to show the effects of two-fold serially diluted concentrations of acetic acid 
and chlorhexidine digluconate on the development of biofilm produced by P. aeruginosa 
following the application and solubilisation of crystal violet dye. CHX = chlorhexidine 
digluconate. Absorbance values were recorded at 570 nanometres (nm). All values represented 
in this table are averages. 
Sample Dilution 
P. aeruginosa & 
CHX (n=3) 
P. aeruginosa & 
Acetic Acid 
(n=3) 
Positive  
Control (n=2) 
Negative 
Control (n=2) 
 1 3.5  
(0) 
0.21  
(0.008) 
0.829 0.204 
 2-1 3.5  
(0) 
0.206  
(0.02) 
0.806 0.182 
 
Absorbance 
2-2 3.5  
(0) 
0.194 
(0.008) 
0.846 0.174 
(arbitrary units) 2-3 3.167  
(0.3) 
0.182 
(0.007) 
0.852 0.18 
 2-4 3.111  
(0.3) 
0.385  
(0.03) 
0.77 0.201 
 2-5 2.882  
(0.6) 
0.63  
(0.1) 
1.17 0.224 
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The ability of ten-fold serial dilutions of chlorhexidine digluconate to inhibit the development 
of biofilm generated by S. aureus was evaluated. Ten-fold serial dilutions of chlorhexidine 
digluconate were used to further distinguish the effects of high and low concentrations of 
chlorhexidine digluconate on the development of biofilm by S. aureus. 
 
Table 9. A table to show the effects of ten-fold serially diluted concentrations of chlorhexidine 
digluconate on the development of biofilm produced by S. aureus following the application 
and solubilisation of crystal violet dye. CHX = chlorhexidine digluconate. Absorbance values 
were recorded at 570 nanometres (nm). All values represented in this table are averages. 
Sample Dilution 
S. aureus & 
CHX (n=2) 
Positive  
Control (n=5) 
Negative 
Control (n=2) 
CHX & 
Tryptone Soya 
broth (n=1) 
 1 3.5 0.470 (0.09) 0.146 3.5 
 10-1 2.183 0.771 (0.1) 0.201 2.732 
 
Absorbance 
10-2 0.219 1.154 (0.1) 0.123 0.242 
(arbitrary units) 10-3 0.148 1.417 (0.2) 0.13 0.125 
 10-4 0.518 1.228 (0.3) 0.121 0.102 
 10-5 3.107 0.868 (0.2) 0.135 0.116 
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MTT Cytotoxicity Assay 
 
The cytotoxicity of two-fold serially diluted concentrations of chlorhexidine digluconate, 
acetic acid, and both quaternary ammonium compounds were evaluated against A549 cells. 
The quantity of formazan produced by viable cells was recorded as an absorbance value at 540 
nanometres (nm). In addition, a reference wavelength of 690 nm was used to eliminate 
background signal interference, such as those generated by precipitates, cellular debris, and 
scratches on the wells. 
 
Table 10. A table to show the cytotoxic effects of two-fold serially diluted concentrations of 
acetic acid, chlorhexidine digluconate (CHX), benzyl-C12-14-alkyldimethylammonium 
chlorides (BAC), and didecyldimethylammonium chloride (DDAC) on A549 cells. The top set 
of values were recorded at 540 nanometres (nm). The bottom set of values represent the 
background signal values, recorded at 690 nanometres. All values represented in this table are 
averages. 
Sample Dilution 
A549 & 
Acetic 
Acid (n=2) 
A549 & 
CHX 
(n=2) 
A549 & 
BAC 
(n=2) 
A549 & 
DDAC 
(n=2) 
Positive 
Control 
(n=2) 
Negative 
Control 
(n=2) 
 1 0.101  
0.083 
1.165 
0.914 
0.258 
0.167 
0.453 
0.304 
0.371 
0.078 
0.077 
0.066 
 2-1 0.243 
0.091 
0.691 
0.464 
0.107 
0.093 
0.108 
0.09 
0.321 
0.089 
0.097 
0.085 
 
Absorbance 
2-2 0.129 
0.104 
0.566 
0.382 
0.143 
0.117 
0.111 
0.095 
0.323 
0.103 
0.104 
0.086 
(arbitrary 
units) 
2-3 0.306 
0111 
0.484 
0.34 
0.148 
0.113 
0.136 
0.114 
0.352 
0.122 
0.129 
0.117 
 2-4 0.301 
0.119 
0.169 
0.139 
0.18 
0.141 
0.166 
0.147 
0.342 
0.13 
0.118 
0.109 
 2-5 0.323 
0.132 
0.186 
0.159 
0.168 
0.151 
0.159 
0.138 
0.385 
0.136 
0.147 
0.128 
 2-6 0.332 
0.155 
0.224 
0.184 
0.211 
0.162 
0.185 
0.158 
0.418 
0.162 
0.153 
0.125 
 2-7 0.489 
0.155 
0.446 
0.17 
0.502 
0.177 
0.452 
0.169 
0.483 
0.163 
0.165 
0.144 
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The cytotoxicity of ten-fold serially diluted concentrations of silver ions, ranging from 0.0074 
mol/L to 0.011 mol/L, and acetic acid were evaluated against A549 cells. 
 
Table 11. A table to show the cytotoxic effects of ten-fold serially diluted concentrations of 
acetic acid and silver ions on A549 cells. The bottom set of values represent the background 
signal values, recorded at 690 nm. All values represented in this table are averages. All values 
represented in this table are averages. 
Sample Dilution 
A549 & Silver 
Ion Solution 
(n=3) 
A549 & Acetic 
Acid (n=2) 
Positive  
Control (n=2) 
Negative 
Control (n=2) 
 1 0.821(0.2) 
0.821(0.2) 
0.104 
0.083 
0.337 
0.081 
0.11 
0.072 
 10-1 0.278(0.05) 
0.225(0.04) 
0.29 
0.1 
0.395 
0.089 
0.122 
0.083 
 
Absorbance 
10-2 0.141(0.02) 
0.105(0.006) 
0.353 
0.109 
0.421 
0.097 
0.119 
0.083 
(arbitrary units) 10-3 0.166(0.006) 
0.119(0.007) 
0.395 
0.13 
0.425 
0.121 
0.148 
0.117 
 10-4 0.292(0.03) 
0.131(0.001) 
0.365 
0.142 
0.417 
0.124 
0.135 
0.105 
 10-5 0.313(0.02) 
0.137(0.01) 
0.336 
0.147 
0.394 
0.127 
0.161 
0.122 
 10-6 0.320(0.02) 
0.157(0.006) 
0.422 
0.178 
0.434 
0.162 
0.175 
0.139 
 10-7 0.353(0.009) 
0.157(0.004) 
0.397 
0.179 
0.415 
0.159 
0.196 
0.158 
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Discussion 
 
The antimicrobial activity of a certified disinfectant hand rub formula and its individual 
formula constituents, including the principal antimicrobial agent chlorhexidine digluconate, 
were evaluated using a selection of different biological assays. In addition, the cytotoxic 
properties of the aforementioned antimicrobial agents against a mammalian cell line were 
evaluated, in parallel, to the antimicrobial assays to provide a comprehensive understanding of 
the overall efficiency of the hand rub formula and its individual constituents. Although it is 
fundamental for antimicrobial formulae to exhibit potent activity against pathogenic microbes 
and ultimately inhibit the spread of disease-causing bacteria, it is equally important for 
antimicrobial formulae to not exhibit significant cytotoxicity. Furthermore, the concept of 
biocompatibility is derived from combining these two aspects of antimicrobial formulae. As 
described by Kramer & Müller (2008), in order to accurately evaluate the suitability of novel 
antimicrobial agents or formulations, both the antimicrobial activity and the potential cytotoxic 
effects must be assessed using in vitro methods in order to generate biocompatible 
antimicrobial agents. 
 
Figure 1. distinctly demonstrates the skin concentrates potent antimicrobial activity against S. 
aureus over a 7-hour incubation period. In the presence of the skin concentrate, the growth of 
S. aureus was inhibited immediately. Furthermore, the growth of S. aureus in the presence of 
the skin concentrate exhibited no revival during the 7-hour incubation period, however an 
extended incubation period could have provided more conclusive data. In addition, this method 
solely provides data associated with the bacteriostatic properties of the skin concentrate. With 
regards to the bactericidal action of the skin concentrate, a more decisive biological assay 
would be required. 
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Table 1. illustrates that all three strains exhibited identical responses when treated with two-
fold serially diluted concentrations of chlorhexidine digluconate. All three strains display an 
OD600 of <0.1 when treated with the 2
-7 dilution; this is indicative of bacterial growth inhibition 
as these values align with the negative control values. Additionally, E. coli and P. aeruginosa 
display optical density values lower than 0.1 for the prior dilution at 2-6. However, the slightly 
more elevated absorbance value for S. aureus, 0.162, could equate to contamination of one of 
the repeats. Wells situated on the edge of 96-well plates were prone to contamination from a 
variety of sources, such as from the equipment being used or from the surrounding atmosphere. 
Additionally, an inadequate number of serial dilutions were used in order to obtain the 
minimum inhibitory concentration (MIC), as the lowest dilution of chlorhexidine digluconate 
generated no turbidity for all three strains. Moreover, all values recorded prior to the 2-5 dilution 
would seemingly indicate extensive growth of bacteria in the treated wells, however this would 
be a false assumption as these elevated optical density values are a by-product of a reaction 
between higher concentrations of chlorhexidine digluconate and Mueller-Hinton broth. 
Furthermore, a precipitation reaction can be assumed due to the fact that the absorbance values 
decrease with decreasing concentrations of chlorhexidine digluconate, thereby indicating that 
reduced concentrations of chlorhexidine digluconate are able to inhibit bacterial growth 
without the generation of an undesired by-product obscuring the effects. 
 
Table 2. distinguishes the effects between high and low concentrations of chlorhexidine 
digluconate on all three strains of bacteria with minimal inference from an undesired by-
product. This was achievable by way of utilising ten-fold serial dilutions. As observed 
previously, all three strains responded identically to chlorhexidine digluconate. All three strains 
display an OD600 of <0.1 when treated with both the 10
-2 and 10-3 dilutions; the slightly elevated 
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value for E. coli, 0.126 at the 10-3 dilution, represents an exception due to possible 
contamination of one of the repeat wells. Furthermore, these values align with the negative 
control values and ultimately indicate bacterial growth inhibition. As bacterial growth was 
observed by all strains when treated with the 10-4 dilution, OD600 of >1, it can be assumed that 
the 10-3 dilution represents the MIC. However, it must be established that ten-fold serial 
dilutions are not as accurate as two-fold serial dilutions in determining the MIC, due to the fact 
that the range between each ten-fold serial dilution is far too extensive. Furthermore, dilutions 
succeeding the 10-3 dilution yield elevated bacterial growth for each strain, more so in the case 
of E. coli and P. aeruginosa, both displaying OD600 values of >1. In addition, the value of 1.083 
at the 10-4 dilution for S. aureus represents an anomaly as the subsequent dilutions yield 
considerably lower absorbance values; OD600 of 0.481-0.604. This could be attributed to a form 
of contamination affecting one of the side wells of the 96-well plate. The results illustrating the 
effects of chlorhexidine digluconate on P. aeruginosa sufficiently portray the activity spectrum 
associated with decreasing concentrations of chlorhexidine digluconate. For example, the first 
two dilutions display elevated absorbance values associated with the generation of an undesired 
by-product between higher concentrations of chlorhexidine digluconate and biological growth 
medium. Both the 10-2 and 10-3 dilutions display bacterial growth inhibition, whereas the 
subsequent dilutions display gradually increasing bacterial densities associated with decreasing 
concentrations of antimicrobial compound. 
 
Table 3. illustrates the activity of chlorhexidine digluconate and the skin concentrate against 
Gram-negative E. coli and Table 4. illustrates the activity of the aforementioned compounds 
activity against Gram-positive S. aureus. The skin concentrate exhibited similar activity against 
both strains, with inhibition of growth observed at both the 10-2 and 10-3 dilutions; far below 
the concentration it is used at. Interestingly, S. aureus did not demonstrate a similar revival in 
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growth compared with E. coli at dilution values below the MIC, with S. aureus displaying 
OD600 values ranging between 0.451-0.757 for both test compounds. Bacterial growth 
associated with S. aureus at sub-MIC concentrations of both compounds seemed constrained, 
albeit marginally increasing. This growth behaviour was observed in Table 2. A possible 
explanation could be the extra outer membrane associated with Gram-negative bacteria, since 
P. aeruginosa displayed elevated bacterial growth at sub-MIC concentrations in Table 2. In 
addition, a column with exclusively chlorhexidine digluconate and growth medium was 
included, in both Table 3. and 4., to highlight the sensitivity Mueller-Hinton broth had for 
higher concentrations of chlorhexidine digluconate, thereby generating a cloudy precipitate. 
Furthermore, with regards to elevated absorbance value associated with E. coli treated with 1 
% (v/v) chlorhexidine digluconate, 0.823, bacterial inhibition could be attributed to the by-
product of the undesired reaction and not solely chlorhexidine digluconate. 
 
Table 5. is a much clearer representation of the antimicrobial effect of two-fold serial dilutions 
of chlorhexidine digluconate against S. aureus and E. coli. Inhibition of both strains is clearly 
indicated at 0.01 % (v/v) and all subsequent dilutions up to 2-5, with OD600 values at <0.1. 
Therefore, the 2-5 dilution can be designated the MIC. Subsequent dilutions for both strains 
indicate a revival in growth similar to the growth patterns observed in Table 2. and 4. The lack 
of undesired background signal interference is attributed to the much lower initial 
concentration, 0.01 % (v/v), which undoubtedly demonstrates chlorhexidine digluconates 
potent antimicrobial activity. 
 
The biofilm assay represented in Table 6. distinctly demonstrates the problematic nature of 
using crystal violet dye to evaluate biofilm inhibitory data. It must be firmly established that 
optical density values can be somewhat misleading with regards to the biofilm inhibition assay 
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due to the staining potency of crystal violet dye. Additionally, due to the abundance of 
experimental aspects associated with the crystal violet assay, several errors could have been 
made that ultimately reduced the amount of biofilm recovered. Visually, it was achievable to 
distinguish the effects of high and low concentrations of test compound against biofilm 
development by changes in the colour intensity of the resolubilised crystal violet dye; a more 
intense crystal violet colour indicated an increased number of adhered microorganisms to the 
well. However, spectrophotometric data could be very misrepresentative with regards to a test 
compounds ability to inhibit biofilm development. Table 6. highlights the high affinity crystal 
violet had for the by-product of the reaction between chlorhexidine digluconate and growth 
medium. In general, the positive controls demonstrated the biofilm-producing properties of S. 
aureus, with an OD570 range of 0.268-0.458. Furthermore, hydrogen peroxide did not react 
readily with the growth medium and demonstrated biofilm-inhibitory properties across all 
concentrations used; OD570 values ranging from 0.201-0.218, which align with the negative 
control values.  It is difficult to extract conclusive information regarding the biofilm inhibitory 
properties of chlorhexidine digluconate, as the strong association between chlorhexidine 
digluconate and the growth medium obscured any beneficial observations. 
 
Table 7. displays results obtained from assessing the inhibitory properties of two broad 
spectrum antimicrobials, hydrogen peroxide and acetic acid, against biofilms associated with 
P. aeruginosa. As they did not react readily with growth medium, the assay produced yielding 
results which clearly represented their activity against biofilm formation. Acetic acid 
demonstrates inhibitory properties at 0.25 % (v/v), although subsequent dilutions do not exhibit 
inhibitory properties. Hydrogen peroxide demonstrates similar inhibitory properties, as it 
displays inhibitory properties at the 2-4 dilution, with an accompanying absorbance value of 
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0.155. In addition, the positive control values are satisfactory, with an OD570 range of 0.427-
0.96, therefore indicative of affluent biofilm development. 
 
Table 8. further demonstrates the common occurrence of misleading results when utilising the 
crystal violet assay to assess biofilm inhibitory properties. All absorbance values associated 
with the biofilm inhibitory properties of chlorhexidine digluconate lie within a range of 2.882-
3.5, thereby making it unfeasible to extract any decisive information. However, It could be 
assumed that chlorhexidine digluconate does demonstrate inhibitory properties against 
biofilms associated with P. aeruginosa by analysing the effects of chlorhexidine digluconate, 
at concentrations far below 2 % (v/v), against planktonic cells associated with P. aeruginosa 
in Table. 2. However, this assumption would have to be suitably assessed before any certain 
claims are made. 
 
Table 9. further distinguishes the effects between high and low concentrations of chlorhexidine 
digluconate by using ten-fold serial dilutions. In addition, a control column with exclusively 
test compound and growth medium was included to highlight that low concentrations of 
chlorhexidine digluconate did not readily chemically react with growth medium. Furthermore, 
ten-fold serial dilutions of chlorhexidine digluconate allowed conclusive data to be obtained, 
since both 10-2 and 10-3 dilutions yielded OD570 values that are indicative of biofilm inhibition; 
0.219 and 0.148 respectively. Furthermore, the slightly higher value for the 10-2 dilution could 
be attributed to a minor reaction between chlorhexidine digluconate and the growth medium. 
Both sets of control values are satisfactory, as they align with the nature of their corresponding 
control type. All negative control values fall between 0.121 and 0.201. The positive control 
values are indicative of unhindered, affluent biofilm development; displaying an OD570 range 
of 0.470-1.417. Closer assessment of tables 4. & 9., concerning S. aureus, seemingly indicate 
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that inhibition of planktonic cell growth and inhibition of biofilm development occur at similar 
concentrations of chlorhexidine digluconate. While this similarity does make sense as reduced 
cell biomass in the well would yield reduced cellular adherence to the well; it does not provide 
insight into the effect of chlorhexidine digluconate on pre-existing biofilms. It would have been 
more prudent to employ a far superior biofilm inhibitory assay which does not require the 
application of crystal violet dye. For example, Ceri et al. (1999) described a biofilm 
susceptibility assay using a Calgary Biofilm Device (CBD), which does not require the 
application of crystal violet dye. In brief, the assay involves cultivating biofilms on specialised 
pegs on a lid and subsequently exposing the biofilms to an antimicrobial compound. Following 
exposure to an antimicrobial compound, the pegs are placed in recovery media. Following 
exposure to recovery media, a new lid is placed in the recovery media and the amount of viable 
biofilm recovered on the pegs is ascertained. Furthermore, due to time limitations and the cost 
of CBDs, the assay was never attempted. 
 
Cytotoxicity data was collected by employing the tetrazolium-based MTT assay. While 
generally more of an accurate assay with regards to the initial starting cell number, the MTT 
assay was laborious and often temperamental due to microbial contamination. In addition, 
microbial contamination of a plate would render the entire assay redundant, whereas microbial 
contamination of a tissue culture flask would make it necessary to restart cell cultivation. 
Furthermore, the immortalised A549 cell line was used since it was an accurate representation 
of a mitotic cell line and its immortalised nature encouraged rapid cultivation. 
 
Table 10. compares the cytotoxic effects of acetic acid, chlorhexidine digluconate, BAC 50, 
and BTC 101E. Acetic acid displayed low levels of toxicity towards A549 compared with the 
other test compounds, with increased viability present at the 2-3 dilution. The absorbance value 
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of 0.243 at the 2-1 dilution can be disregarded due to fact that the subsequent dilution displayed 
a reduction in viability. Furthermore, the elevated absorbance value associated with the 2-1 
dilution could be attributed to microbial contamination. In addition, the aforementioned 
absorbance value could be attributed to an experimental error, such as the application of an 
incorrect dilution or lack of attentiveness which resulted in no test compound being applied. 
Interestingly, compared with its ability to inhibit biofilm development, acetic acid displayed 
more potent behaviour towards A549. More conclusive data could be obtained by directly 
assessing acetic acid against pre-existing biofilms. Two-fold serial dilutions of chlorhexidine 
digluconate, BAC 50, and BTC 101E all display similar toxicity levels against A549. As 
observed in the antimicrobial studies, higher concentrations of chlorhexidine digluconate react 
with the mammalian cell growth media to generate elevated absorbance values up to the 2-3 
dilution; this is followed by a reduction in absorbance, 0.169 and 0.186, which is suggestive of 
a reduction in viability. Viable cells were present at the 2-7 dilution for all three compounds, 
however toxicity was observed as low as the 2-6 dilution; OD540 of 0.224 in the case of 
chlorhexidine digluconate which indicates minimal increase in viability. For chlorhexidine 
digluconate, this would equate to a concentration of 0.008 % (v/v) and 0.02 % (v/v) 
respectively. Regarding its effects on E. coli and S. aureus, growth inhibition was observed as 
low as the 2-7 dilution; equating to a concentration of 0.02 % (v/v). While these results would 
appear favourable, the minimum bactericidal concentration (MBC) would surpass this 
concentration, thereby indicating that chlorhexidine digluconate would be deployed in a 
formula at a concentration greater than the MBC. Both quaternary ammonium compounds 
demonstrated elevated toxicity against A549, with significant viability, OD540 of 0.502 and 
0.452, demonstrated at the 2-7 dilution for both compounds. 
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Table 11. illustrates that a concentrated solution of silver ions displayed cytotoxic behaviour at 
the 10-3 dilution; OD540 of 0.166 which aligns with the negative control values. All subsequent 
dilution values indicate a revival in viability; 0.292, 0.313, 0.320, and 0.353. The toxic 
properties of silver ions are even more distinct when the toxic properties of acetic acid are 
included, with viability observed at the 10-1 dilution. However, quantitative assessment of the 
silver ion solution revealed it to be very saturated, thus the concentration could not be 
determined accurately. Furthermore, an extensively saturated silver ion solution would 
undoubtedly exert cytotoxic activity against a 96-well plate of adherent mammalian cells 
swathed in growth medium. 
 
The results obtained throughout the course of the research are conclusive with regards to the 
antimicrobial potency of the skin concentrate formula and its principal antimicrobial 
constituent, chlorhexidine digluconate. All the assays used to analyse antimicrobial activity 
yielded convincing data that is indicative of potent antimicrobial activity. However, to yield 
more quantitative data with regards to remaining viable bacterial cells, a quantitative 
suspension test could have been employed. On occasion, it was difficult to derive reliable data 
when chlorhexidine digluconate was concerned as it commonly reacted with growth medium. 
In order to combat the problem concerning chlorhexidine digluconates tendency to react with 
liquid growth medium and ultimately hinder the detection of bacterial growth, it might have 
been more beneficial to employ the agar dilution method. The agar dilution method involves 
assessing an antimicrobial compounds capabilities on a solid agar surface, thus an undesired 
reaction between chlorhexidine digluconate and the agar medium might not have occurred. 
Regrettably, the agar dilution method was never attempted. In addition, biofilm inhibitory data 
was unyielding in certain aspects due to the problematic nature of crystal violet dye and the 
laborious methodology associated with the assay. Silver ions in solution displayed 
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antimicrobial activity; coinciding with scientific literature concerning the antimicrobial activity 
of silver. However, the method employed to generate silver ions was very rudimentary, and as 
a consequence, a heavily saturated solution of silver ions was produced. Furthermore, while 
ionic silver is recognised for its antimicrobial activity, the antimicrobial efficacy of silver 
nanoparticles represents a more recent area of interest. Although results and experimental 
procedures are not presented here, silver nanoparticle generation was attempted using a method 
outlined by Mir-Simon et al. (2015). However, despite the presence of silver nanoparticles 
being confirmed by ultraviolet-visible spectroscopy (UV-Vis), detailed characterisation could 
not be achieved at the University of Salford, thus antimicrobial evaluation was not attempted. 
Minimum bactericidal concentration (MBC) data was scarce owing to the fact that results were 
either incomprehensible due to contamination, or there was no outcome whatsoever to derive 
conclusions from. No outcome could be attributed to the requirement of a neutralising agent to 
neutralise the effects of the antimicrobial agent while being transferred to the appropriate agar 
to establish viability. Regrettably, time limitations and other aspects of the research prevented 
further investigation into the MBC. 
 
Regardless of the potent antimicrobial activity of chlorhexidine digluconate, cytotoxicity data 
confirmed the toxic effects of chlorhexidine digluconate against mammalian cells. In addition, 
silver ions demonstrated cytotoxicity towards mammalian cells. However, particular aspects of 
the cytotoxic studies were unyielding due to the fact that the mammalian growth medium 
frequently reacted with all test compounds at higher concentrations. In addition, a marginal 
difference could occasionally be detected between both control values; this could be attributed 
to an experimental error that produced an insufficient amount of cells being plated per well. 
Whereas the mammalian cell line used was a lung carcinoma cell line, it still was a mitotic cell 
line of human origin. However, more conclusive data could be harvested from cytotoxic 
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evaluation against fibroblasts and keratinocytes. With regards to cytotoxicity testing, more data 
with regards to structural damage would have generated a wider understanding of the toxic 
effects of the antimicrobial agents. While not particularly within the realms of an MSc (By 
Research) project, structural analysis using transmission electron microscopy (TEM) following 
treatment in order to explore the various signalling pathways that could be associated with 
antimicrobial-induced mammalian cell death using a fluorescent dye, such as Fluo-3 AM, 
would have yielded far more extensive data. 
 
The comparison between antimicrobial activity and cytotoxicity of antimicrobial compounds 
represents a very significant area of research due to the widespread application of antimicrobial 
compounds in different settings. Since topical antimicrobial compounds are applied to the skin 
habitually, it is important that toxic side effects are at an absolute minimum. The concept of 
biocompatibility is especially crucial in the medical setting, as there are an abundance of 
debilitated persons, thus creating an opportunistic environment for bacteria to flourish. In order 
to imitate in vivo scenarios as accurately as possible, an assortment of in vitro assays have been 
developed and enhanced in recent years. While not all of those assays have been reported here 
in an experimental sense, the ones that have been attempted provide an invaluable insight into 
the antimicrobial and cytotoxic activity of antimicrobial compounds. 
 
In terms of results achieved over the course of the research, it was not possible to include all 
the data that was collected because of the quantity, and on occasion, the incomprehensible 
nature of them. The generation of unintelligible data was commonplace, since a lot of 
techniques performed over the course of the research required a substantial amount of practice 
to achieve a satisfactory level of self-confidence. Though assays demand a great deal of 
practice to achieve clear results, important intermediate steps, such as bacterial inoculations, 
98 
 
often require the same level of persistent practice. The next step of this research could be the 
habitual application of skin concentrate on a random collection of individuals to monitor its 
effect over a premeditated time period, using alcohol-containing formulae to serve as controls. 
Dyer, Gerenraich & Wadhams (1998) performed a study evaluating the immediate and 
persistent antimicrobial properties associated with rinse-free hand sanitisers on hands that had 
been purposefully contaminated with a particular species of bacteria. In brief, the 
aforementioned study involved contaminating hands with bacteria and subsequently applying 
the appropriate antimicrobial formulation. Following a standardised washing protocol, the 
glove juice sampling method was employed in order to extract the initial bacterial sample; this 
was achieved using a collection fluid. Furthermore, collection samples were then plated on the 
appropriate agar to obtain accurate colony counts. In addition, to ensure straightforward 
analysis of the effectiveness of an antimicrobial formulation, Dyer et al. (1998) used Serratia 
marcescens in the study which grows in red-coloured colonies. In vivo evaluations offer more 
reliable data, however lack of available time and ethical matters prevented any work being 
done in this area. 
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